Log In

Forgot Password?
Create New Account

Loading... please wait

2023 Annual Meeting | P10 - Poster Session 10

Wednesday 04/26/23
08:00 AM - 09:00 AM EST Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Neuro-oncology, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Child Neurology and Developmental Neurology, Education, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG)
0.00 CME credit
Event Timeline
08:00 AM - 09:00 AM EST Abstract 9-001 - Characterizing EEG and Serum Biomarker Trends in Immune Effector Cell-Associated Neurotoxicity: A Case Series
Andrew M. Nguyen, MD
08:00 AM - 09:00 AM EST Abstract 9-002 - Algorithm to Annotate Epileptiform Abnormalities in EEG Reports
Rachel S. Choi
08:00 AM - 09:00 AM EST Abstract 9-003 - EEG patterns in Refractory Epilepsy with Focal Cortical Dysplasia and predictors of outcome after surgery
Anuja R. Patil, MD, DM
08:00 AM - 09:00 AM EST Abstract 9-004 - A simultaneous intracranial EEG- surface EMG analysis of generalized tonic-clonic seizures
Aybuke Acar, MD
08:00 AM - 09:00 AM EST Abstract 9-005 - Provider and Patient Opinions on Real-Time Seizure Detection via Over-the-Ear Device
Pooja Venkatesh
08:00 AM - 09:00 AM EST Abstract 9-006 - Automated Seizure Detection and Management using CERIBELL: A single center cohort study
Ajay Rajshekar, DO
08:00 AM - 09:00 AM EST Abstract 9-007 - Clarity Interpretation of Ceribell Rapid Response Electroencephalography Use Shows Limited Influence on Patient Disposition and Outcome
Michael A. Connerney, MD
08:00 AM - 09:00 AM EST Abstract 9-008 - The role of the perioperative use of EEG as a predictor/diagnostic tool for post-operative delirium: Systematic Review
Maria J. Bruzzone, MD
08:00 AM - 09:00 AM EST Abstract 9-009 - Automated Detection of Central-positive Complexes & Postictal Generalized EEG Suppression in ECT-induced Seizures – An Illustrative Case Report
Chetan Nayak, MD
08:00 AM - 09:00 AM EST Abstract 9-010 - Signs of Electro-cortical Disconnection revealed by Hd-EEG in Acute Stroke Patients: a Case Study.
Elena Monai, MD
08:00 AM - 09:00 AM EST Abstract 9-011 - EEG Analysis of Eye Movement Artifact in Parietal and Occipital Lobe Seizures: A Search for Epileptic Nystagmus
Aybuke Acar, MD
08:00 AM - 09:00 AM EST Abstract 9-012 - Temporal dynamics of triphasic waves and generalized periodic discharges
George Plummer, MD
08:00 AM - 09:00 AM EST Abstract 15-001 - The Role of Neurology Residency Programs Presence on Social Media During Residency Application
Cleo Zarina A. Reyes, MD
08:00 AM - 09:00 AM EST Abstract 15-002 - @NMatch2023: A Student-Led Social Media-Based Initiative to Guide Adult and Child Neurology Residency Applicants and Programs in a Digital Era
Nupur N. Goel, MD
08:00 AM - 09:00 AM EST Abstract 15-004 - Survey on the Fellowship Application Timeline for UCNS-accredited Behavioral Neurology and Neuropsychiatry Programs
Sylvia Josephy, MD
08:00 AM - 09:00 AM EST Abstract 15-005 - A Survey of Medical Education Pathways in Neurology Residency Programs
Taha Qarni, MD
08:00 AM - 09:00 AM EST Abstract 3-001 - Novel Pathways Correlating with MS-Related Tremor, A Case-Control Study
Ahmed A. Bayoumi
08:00 AM - 09:00 AM EST Abstract 3-002 - Quantification of Thalamic Volume in Multiple Sclerosis: From the Multicenter INNI Dataset Towards the Clinical Application
Paolo Preziosa
08:00 AM - 09:00 AM EST Abstract 3-003 - Third Ventricle Width is a Reliable and Clinically-Feasible Marker of Brain Atrophy in the Multiple Sclerosis Clinical Care Setting
Sarah Levy, PhD
08:00 AM - 09:00 AM EST Abstract 3-004 - Correspondence Among Gray Matter Damage and Neurotransmitter Maps Is Clinically Relevant in Multiple Sclerosis
Paolo Preziosa
08:00 AM - 09:00 AM EST Abstract 3-005 - Myelin Density in Normal-Appearing White Matter in Measurements by q-Space Diffusional MRI Correlates with Clinical Disability in Multiple Sclerosis
Haruhiko Motegi, MD
08:00 AM - 09:00 AM EST Abstract 3-006 - Loss of gyrification is associated with disability progression in multiple sclerosis
Jonadab Dos Santos Silva
08:00 AM - 09:00 AM EST Abstract 3-007 - Gray Matter Microstructure Alterations in People with Multiple Sclerosis Based on Cell Body and Neurite Density Imaging
Eva Angela Krijnen
08:00 AM - 09:00 AM EST Abstract 3-008 - Functional Connectivity Modifications in Monoaminergic Circuits Occur in Fatigued MS Patients Treated With Fampridine and Amantadine
Paolo Preziosa
08:00 AM - 09:00 AM EST Abstract 3-009 - Choroid Plexus Enlargement in Pediatric Multiple Sclerosis: Clinical Relevance and Effect of Sex
Paolo Preziosa
08:00 AM - 09:00 AM EST Abstract 3-010 - The Insula Modulates the Effects of Aerobic Training on Cardiovascular Function and Ambulation in Multiple Sclerosis
Paolo Preziosa
08:00 AM - 09:00 AM EST Abstract 3-011 - Progression independent of relapses in multiple sclerosis is associated with spinal cord and brain atrophy
Kunio Nakamura, PhD
08:00 AM - 09:00 AM EST Abstract 3-012 - Upper Cervical Cord Volume and Its Association with Brain Metrics in MS
Nur Neyal, MD
08:00 AM - 09:00 AM EST Abstract 3-013 - Vitreomacular Interface Abnormalities in Multiple Sclerosis; A Novel Signature of Disability
Hussein Moussa, MD
08:00 AM - 09:00 AM EST Abstract 3-014 - Time-Varying Functional Connectivity of the Hippocampus Is Associated With Cognitive Performance in Multiple Sclerosis Patients
Paolo Preziosa
08:00 AM - 09:00 AM EST Abstract 3-015 - Radiomics-based Unsupervised Clustering of Acute Multiple Sclerosis Lesions
Bastien C. Caba
08:00 AM - 09:00 AM EST Abstract 3-016 - Choroid Plexus Enlargement In Systemic Lupus Erythematosus: Relationship With Auto-Antibody Status And Neuropsychiatric Involvement
Paolo Preziosa
08:00 AM - 09:00 AM EST Abstract 3-017 - Myelin Water Fraction of Slowly Evolving Lesions is Associated With Disability in Multiple Sclerosis
Shannon Kolind, PhD, MSc, BSc
08:00 AM - 09:00 AM EST Abstract 3-018 - Longitudinal Changes of Functional Connectivity Dynamism Are Relevant for Disability Worsening in Multiple Sclerosis: A 2.5-Year Study
Paolo Preziosa
08:00 AM - 09:00 AM EST Abstract 12-002 - Reduced Frequencies of Post-Lumbar Puncture (LP) Headaches and Epidural Blood Patch Needs with Modifications of Standard LP Procedure
Jay-Jiguang Zhu, MD, PhD, FAAN
08:00 AM - 09:00 AM EST Abstract 12-003 - Idiopathic Intracranial Hypertension Causing Polyradiculopathy and Areflexia
Anjali Kamath
08:00 AM - 09:00 AM EST Abstract 12-004 - Role of Obstructive Sleep Apnea in Idiopathic Intracranial Hypertension
Mangayarkarasi Thandampallayam Ajjeya, MBBS
08:00 AM - 09:00 AM EST Abstract 12-005 - Chiari I malformation: Clinical Characteristics, Symptoms, and Presentations.
Yazan S. Al-Zamer
08:00 AM - 09:00 AM EST Abstract 12-006 - The Queen Square Adult Leukodystrophy Group: 10 years-experience of a multidisciplinary diagnostic service
Charles L. Wade, MBBS
08:00 AM - 09:00 AM EST Abstract 12-007 - Five Creutzfeldt-Jakob Disease Cases Within One Year in Spectrum Health Hospitals in Grand Rapids, Michigan
Jiangyong Min, MD
08:00 AM - 09:00 AM EST Abstract 6-001 - Rapidly Progressive AIDP Secondary To Waldenström’s Macroglobulinemia, A Rare Cause With Fatal Respiratory Depression And Autonomic Instability
Hongxuyang Yu, MD
08:00 AM - 09:00 AM EST Abstract 6-002 - Guillain-Barré Syndrome Following Primary Cytomegalovirus Infection in a Patient with Liver Transplantation: a Case Report
Jaime Toro, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 6-003 - A Curious Case of Cocaine-Induced Hypokalemic Periodic Paralysis Mimicking Guillain-Barre Syndrome
Elizabeth G. Baumann, MD
08:00 AM - 09:00 AM EST Abstract 6-005 - Ataxic variant of Guillain-Barre syndrome, with positive GD1b antibodies in an elderly male: a case report
Camelia Valhuerdi Porto, MD
08:00 AM - 09:00 AM EST Abstract 6-006 - Global Mortality of Chronic Inflammatory Demyelinating Polyneuropathy Patients Treated with Intravenous Immunoglobulin versus Steroid Therapies
Kazim Jaffry
08:00 AM - 09:00 AM EST Abstract 6-007 - Design of a Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Nipocalimab in Participants with Active Idiopathic Inflammatory Myopathies (SPIREA)
Catherine Najem, PhD
08:00 AM - 09:00 AM EST Abstract 6-008 - Preclinical Assessment of EPO-Derived Peptide JM4 in Experimental Autoimmune Neuritis
Gabriel R. Arismendi, MD
08:00 AM - 09:00 AM EST Abstract 6-010 - Ibrutinib in Anti-MAG Neuropathy with Waldenstrom Macroglobulinemia
Zabeen K. Mahuwala, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 6-011 - Cellular and In Vivo Preclinical Pharmacodynamics and Pharmacology of Nipocalimab, an Anti-FcRn Blocking Therapeutic Antibody
Leona Ling, PhD
08:00 AM - 09:00 AM EST Abstract 6-012 - SARS-CoV-2 Vaccine Immune Response on Anti-Complement Therapy, Eculizumab
Neda Sattarnezhad Oskouei, MD
08:00 AM - 09:00 AM EST Abstract 6-013 - Intravenous Immunoglobulin Therapy for Autoimmune Dysautonomia in children: A Case Series
Alexander Bolufer
08:00 AM - 09:00 AM EST Abstract 6-014 - Diagnosed in the Autoimmune Neurology Clinic: Two patients with different phenotypes of spinocerebellar ataxia type 27
Yoji Hoshina, MD
08:00 AM - 09:00 AM EST Abstract 6-015 - Do Statins Have a Protective Effect Against Neuro-Autoimmune Disease and Comorbidity?
Mohsen Ahmed
08:00 AM - 09:00 AM EST Abstract 6-016 - Are Insulin Mimetics Protective Against Comorbidity in Patients With Neuro-Autoimmune Disease?
Mohsen Ahmed
08:00 AM - 09:00 AM EST Abstract 6-018 - Evidence of Neuroinflammation and Immunotherapy Responsiveness in Individuals with Down Syndrome Regression Disorder
Jonathan Santoro, MD
08:00 AM - 09:00 AM EST Abstract 6-019 - Machine learning-driven Interferon Signaling Gene Expression Score predicts Aicardi Goutières Syndrome
Adeline Vanderver, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 6-020 - Recurrent Bickerstaff Encephalitis: Clinical Manifestation and Potential Treatment Options
Ketevan Amirkhanashvili, MD
08:00 AM - 09:00 AM EST Abstract 6-021 - Neuromyelitis Optica Spectrum Disorder (NMOSD) Relapse Triggered by Secondary Syphilis: A Case Report
Luiza Lima, MD
08:00 AM - 09:00 AM EST Abstract 6-022 - Acute transverse myelitis (ATM) associated with COVID 19 infection and vaccination, A case report and literature review.
Srinivas Medavarapu, MD, MBBS
08:00 AM - 09:00 AM EST Abstract 6-023 - COVID-19 Infection Linked to MOG Antibody-Associated Disease (MOGAD): Case Report
Gira I. Graciano, MD
08:00 AM - 09:00 AM EST Abstract 6-024 - Osmotic Demyelinating Syndrome Secondary to Breast Cancer Chemotherapy: a Case Report
Jairo A. Gaitan Alfonso, MD
08:00 AM - 09:00 AM EST Abstract 6-025 - A Tale of Two Cases: When to Use PLEX That is The Question
Michael Grunstein, DO
08:00 AM - 09:00 AM EST Abstract 6-026 - Cryoglobulinemia and Neuromyelitis optica: a case of progressive weakness and neurocognitive decline
Aimalohi Esechie, MD, PhD
08:00 AM - 09:00 AM EST Abstract 6-027 - AMPA receptor antibody encephalitis in a patient with Myasthenia Gravis post thymectomy
Samantha De Gannes, MD
08:00 AM - 09:00 AM EST Abstract 6-029 - Isolated Brainstem Involvement and Low Titer MOG antibody as the Initial Presentation of MOG Antibody Disease
Cynthia X. Wang, MD
08:00 AM - 09:00 AM EST Abstract 6-031 - “Novel Psychiatric Manifestations of Anti-MOG Antibody Disease”
Faiza Ahmed
08:00 AM - 09:00 AM EST Abstract 7-001 - Cerebrospinal Fluid Neurofilament Light as a Marker of Neuro-axonal Injury in Normal Pressure Hydrocephalus
Foad Taghdiri, MD, MSc
08:00 AM - 09:00 AM EST Abstract 7-002 - Feasibility of Neurofilament Light Chain as a Blood-Based Biomarker for Screening Across Neurological Diseases
Briana Cameron, PhD
08:00 AM - 09:00 AM EST Abstract 7-004 - Association Between Cerebrospinal Fluid Biomarkers of Amyloid and Tau and Neuropsychiatric Symptoms Among Participants from the National Alzheimer’s Coordinating Center Uniform Data Set
Michael Walsh, Other
08:00 AM - 09:00 AM EST Abstract 7-005 - Association of Alzheimer’s Plasma Biomarker Concentrations with Body Mass Index in Older Adults
Serena S. Hoost
08:00 AM - 09:00 AM EST Abstract 7-006 - Identification of Plasma Biomarkers for Brain Endothelial Function
Jenifer Cordon
08:00 AM - 09:00 AM EST Abstract 7-008 - Assessment of Plasma Biomarkers by ImmunoMagnetic Reduction in Parkinson's Disease Dementia and Dementia with Lewy Bodies
Giovanni R. Malaty, MD
08:00 AM - 09:00 AM EST Abstract 7-009 - Influencing factors of plasma BACE1 and its relationship with plasma Aß: A cross-sectional study of a cognitively normal population of Shunyi cohort
08:00 AM - 09:00 AM EST Abstract 7-010 - Plasma neurofilament light chain predicts Alzheimer’s pathology and progression of cognitive decline in patients with subjective cognitive decline and mild cognitive impairment: a longitudinal study
Salvatore Mazzeo
08:00 AM - 09:00 AM EST Abstract 1-001 - Reversible Splenial Lesion Syndrome (RESLES) in Sickle Cell Crisis Mimicking Marchiafava-Bignami Disease
Yohannes S. Mulatu, MD
08:00 AM - 09:00 AM EST Abstract 1-002 - An Unusual Case of Posterior Fossa Predominant Posterior Reversible Encephalopathy Syndrome (PRES) Leading to Acute Hydrocephalus
Shalane A. Morales-Nunez, MD
08:00 AM - 09:00 AM EST Abstract 1-003 - A Case of Brainstem Predominant PRES
Jonathan Rosenthal, MD
08:00 AM - 09:00 AM EST Abstract 1-004 - Cranial ultrasound image acquisition in a moving ambulance feasibility for pre-hospital EMS applications: A review of literature
Benjamin Malinda
08:00 AM - 09:00 AM EST Abstract 1-005 - Recurrent PRES after initiation of R-EPOCH & Methotrexate: A Case Study.
Lauren Nelson, MD
08:00 AM - 09:00 AM EST Abstract 1-006 - Severe Hypoglycemic Brain Injury Associated with Diffuse Restricted Diffusion on MRI Brain Sparing Cerebellar Lobes
Estevao P. Ribeiro, MD
08:00 AM - 09:00 AM EST Abstract 10-001 - Healthy astrocytes provide neuroprotection against apolipoprotein B-100-induced motor neuron degeneration
Rose P. Griffin
08:00 AM - 09:00 AM EST Abstract 10-002 - Bax inhibitor protects against apolipoprotein B-100-induced human motor neuron degeneration in vitro
Ivy Gao
08:00 AM - 09:00 AM EST Abstract 10-003 - Non-Invasive Mechanical Ventilation slows motor decline in Amyotrophic Lateral Sclerosis: a population-based study
Maurizio Grassano, MD
08:00 AM - 09:00 AM EST Abstract 10-004 - A large kindred with familial ALS due to the KIF5A p.Arg1007Lys mutation
Jaroslaw Dulski, MD, PhD
08:00 AM - 09:00 AM EST Abstract 10-005 - Clinical and genetic characteristics associated with ALS diagnostic timeline: a population-based study
Peter P. Pacut, MD
08:00 AM - 09:00 AM EST Abstract 10-006 - Motor Nerve Conduction Slowing in Amyotrophic Lateral Sclerosis
Kranthi K. Mandava
08:00 AM - 09:00 AM EST Abstract 10-007 - Evaluation of Gastrointestinal Symptoms in an ALS Cohort
Rizamarie Empeno, MD
08:00 AM - 09:00 AM EST Abstract 10-008 - Long-term follow-up of five families from Turkey with UBQLN2 variants
Hacer Durmus, MD
08:00 AM - 09:00 AM EST Abstract 10-009 - At-Home Telespirometry (AHT) in Amyotrophic Lateral Sclerosis (ALS): Digital Health Technology and Quality Control
Bhavya Narapureddy, MBBS
08:00 AM - 09:00 AM EST Abstract 10-010 - C9orf72-related Familial Amyotrophic Lateral Sclerosis Manifesting as Monomelic Amyotrophy of the Lower Extremity
Clover Youn, MD
08:00 AM - 09:00 AM EST Abstract 10-011 - Analysis of Amyotrophic Lateral Sclerosis (ALS) Clinical Trials Posted on www.clinicaltrials.gov from 1999-2022.
Aaron Zelikovich, MD
08:00 AM - 09:00 AM EST Abstract 10-012 - Real World Data as a control group, an ALS case study
Matteo Locatelli, BS
08:00 AM - 09:00 AM EST Abstract 10-013 - Association Between Amyotrophic Lateral Sclerosis Age at Diagnosis and Comorbid Conditions
Mustafa Jaffry
08:00 AM - 09:00 AM EST Abstract 10-014 - Small Molecule Modulators of Metabolic Dysfunction as a Therapeutic Strategy For ALS
Daniel Kaganovich
08:00 AM - 09:00 AM EST Abstract 10-015 - Parasympathetic cardiac dysfunction in Amyotrophic Lateral Sclerosis
Cecilia Quarracino Benchetrit, MD
08:00 AM - 09:00 AM EST Abstract 4-001 - Fetal Neurology Practice Survey
Tomo Tarui, MD
08:00 AM - 09:00 AM EST Abstract 4-002 - Relationship Between Maternal Antibodies to Fetal Brain and Prenatal Stress Exposure in Autism Spectrum Disorder
David Q. Beversdorf, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 4-003 - Epilepsy surgery in a neonate: Resection of Right Temporal Neocortical Focal Cortical Dysplasia in a Three-Week-Old Infant.
Prasanna Gangishetti, MBBS
08:00 AM - 09:00 AM EST Abstract 4-005 - Microglia Maintain Homeostatic Conditions in the Developing Rostral Migratory Stream
Sarah J. Meller, PhD
08:00 AM - 09:00 AM EST Abstract 4-006 - Temporal Silencing of Purkinje Cell Neurotransmission Reveals a Dynamic Role for Cerebellar Function in Neurodevelopment
Jason S. Gill, MD, PhD
08:00 AM - 09:00 AM EST Abstract 4-008 - Distinct Etiologies of RANBP2-negative Acute Necrotizing Encephalopathy of Childhood
Vaishnavi L. Vaidyanathan, MD
08:00 AM - 09:00 AM EST Abstract 4-009 - Longitudinal Assessment of High- and Low-Contrast Visual Acuity in Normally-Sighted Children
John R. Sollee
08:00 AM - 09:00 AM EST Abstract 4-010 - Valproic Acid is an Effective Anti-Emetic Treatment in Alexander Disease
Emily Sergio, Other
08:00 AM - 09:00 AM EST Abstract 4-011 - Natural History of Seizures in Alexander Disease
Kathryn Gallison, Other
08:00 AM - 09:00 AM EST Abstract 4-012 - Top Caregiver Concerns for Individuals with the Ultra-Rare X-linked HNRNPH2-Related Neurodevelopmental Disorder
Juliana Nitis
08:00 AM - 09:00 AM EST Abstract 13-001 - Candida dubliniensis Meningitis in Immunocompetent Adults - case report and review of literature
Lucas Horta, MD
08:00 AM - 09:00 AM EST Abstract 13-002 - Neuroaspergillosis: Challenging Diagnosis and Management
Stephen Jaworski, MD
08:00 AM - 09:00 AM EST Abstract 13-003 - The Many Manifestations of Rhino-Orbital-Cerebral Mucormycosis: An Illustrative Case Report
Megan E. Trenz, DO
08:00 AM - 09:00 AM EST Abstract 13-004 - Invasive Optic Nerve Aspergillosis with Intracranial Extension in an Immunocompetent Patient
Sukhraj Gill, MD
08:00 AM - 09:00 AM EST Abstract 13-006 - Bilateral Disc Edema Heralding Ocular Syphilis: A Case Series
Taylor R. Anderson, MD
08:00 AM - 09:00 AM EST Abstract 13-007 - Neurosyphilis Presenting as Limbic Encephalitis: a Case Report
Calvin Hu, MD
08:00 AM - 09:00 AM EST Abstract 5-001 - Reducing the Receipt of Contraindicated Medications for Patients with Parkinson’s Disease
Caroline Goldin, MD
08:00 AM - 09:00 AM EST Abstract 5-002 - Community-Academic Initiative to Measure and Improve Underrepresented Group Participation in Parkinson's Disease Research
Anabel Marre, Other
08:00 AM - 09:00 AM EST Abstract 5-003 - Leveraging patient-reported outcomes to discern mobility trajectories in Parkinson’s disease
Farren Briggs, PhD
08:00 AM - 09:00 AM EST Abstract 5-004 - Functional Outcomes of an Intensive Multimodal Rehabilitation Intervention for Moderately Advanced Parkinson's Disease
Priyanka Moondra, DO
08:00 AM - 09:00 AM EST Abstract 5-005 - Distance Travelled by patient for appointment with the Movement disorder clinic at Kentucky Neuroscience Institute – how to solve the problem?
Sindhura Tadisetty
08:00 AM - 09:00 AM EST Abstract 5-006 - Prioritizing Racial Representation in Treating People with Parkinson’s Disease: An Assessment of Racial Inclusion Among Parkinson’s Disease Clinical Trials between 1999-2022.
Vivien Ikwuazom
08:00 AM - 09:00 AM EST Abstract 5-007 - Neurologists’ Likelihood of Prescribing Injectable Parkinson’s disease (PD) Therapies Increases With Education on Patient Attitudes
Rajeev Kumar, MD, FRCPC
08:00 AM - 09:00 AM EST Abstract 5-008 - Continued usage of Parkinson's worsening drugs in patients diagnosed with Parkinson's disease – What can be done to solve this problem.
Sindhura Tadisetty
08:00 AM - 09:00 AM EST Abstract 5-009 - Evaluation of the Clinical Outcomes and Disease Burden in Advanced Parkinson’s Disease Patients: PROSPECT Study Preliminary Results
Pavnit Kukreja, PharmD
08:00 AM - 09:00 AM EST Abstract 5-010 - Improving Shared Decision-Making for Women with Parkinson’s Disease
Michelle Fullard, MD
08:00 AM - 09:00 AM EST Abstract 5-011 - Neurological Exam Findings Predictive of Falls in Patient’s with Parkinson’s Disease
Allison R. Valerius, MD
08:00 AM - 09:00 AM EST Abstract 5-012 - Clinical Utility of Home-to-Home Tele-neuropsychology (TeleNP) in the Assessment of Post-Operative Deep Brain Stimulation (DBS) Outcomes in Parkinson’s disease (PD) Patients
Hannah M. Bullock
08:00 AM - 09:00 AM EST Abstract 5-013 - Feasibility and Utility of Electrophysiology-Based DBS Programming in Clinical Practice.
Dylan F. Del Papa, MD
08:00 AM - 09:00 AM EST Abstract 5-014 - Assessment of Virtual Reality Devices as a Means of Objectively Monitoring Parkinson’s Disease
Siegfried Hirczy, MD
08:00 AM - 09:00 AM EST Abstract 5-015 - Characterizing Hospital Admissions in Persons with Parkinson’s Disease: 10-Year Retrospective Study of Administrative Data in Alberta, Canada
Yasamin Mahjoub, MD
08:00 AM - 09:00 AM EST Abstract 2-001 - Persistence to OnabotulinumtoxinA or Calcitonin Gene-Related Peptide Monoclonal Antibody Therapy Among Patients With Migraine: A Retrospective Cohort Study
Seema Soni-Brahmbhatt
08:00 AM - 09:00 AM EST Abstract 2-002 - Initiation of Fremanezumab Earlier in the Treatment Cycle may Result in Cost Savings to Payors in the United States
08:00 AM - 09:00 AM EST Abstract 2-003 - Efficacy and safety of different doses of subcutaneous galcanezumab in chronic and episodic migraine: A pooled analysis of 3651 patients
08:00 AM - 09:00 AM EST Abstract 2-004 - Real-world Adherence to Subsequent CGRP mAb Treatment Among Chronic Migraine (CM) Patients Initially Treated with OnabotulinumtoxinA: A Retrospective Claims Analysis
Tae Jin Park
08:00 AM - 09:00 AM EST Abstract 2-005 - Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Migraine
Elise R. Hennessy, MD
08:00 AM - 09:00 AM EST Abstract 2-006 - Treatment with Galcanezumab in Patients with Episodic Migraine: Results from the Open-Label Phase of the PERSIST Study
Maurice B. Vincent, MD, PhD
08:00 AM - 09:00 AM EST Abstract 2-007 - Adherence and Persistence among Patients with Migraine Initiating Concomitant Use of Self-Injectable Calcitonin Gene-related Peptide Monoclonal Antibody and Novel Acute Migraine Medications
Oralee J. Varnado, PhD
08:00 AM - 09:00 AM EST Abstract 2-008 - Beyond migraine headache day reduction: Clinically meaningful improvement in disability (MIDAS score) in the absence of greater than 50% reductions in monthly migraine days with galcanezumab
Bert B. Vargas, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 2-009 - Long-Term Safety and Tolerability of Zavegepant 10 mg Nasal Spray During Concomitant Use of CGRP Monoclonal Antibodies: Results From a 1-Year Open-label Safety Trial
Gary D. Berman, MD
08:00 AM - 09:00 AM EST Abstract 2-010 - Effects of Rimegepant 75 mg on Monthly Migraine Days: a 52-Week, Open-Label Extension Study
Robert Croop, MD
08:00 AM - 09:00 AM EST Abstract 2-011 - Medication Preference, Satisfaction, and Clinical Improvement Among Adults Receiving Long-Term Treatment With Rimegepant for Migraine
Kathleen B. Mullin, MD
08:00 AM - 09:00 AM EST Abstract 2-012 - Post Hoc Analysis of PROGRESS: Evaluating the Safety of Atogepant in Participants With Chronic Migraine and Cardiovascular Risk Factors
Stephanie J. Nahas, MD, FAAN
08:00 AM - 09:00 AM EST Abstract 11-001 - Neurological Outcomes of Radiosurgery for Brain Metastases in the Motor Cortex
Shefalika Prasad
08:00 AM - 09:00 AM EST Abstract 11-002 - Peritumoral edema measurements provide additional information to RANO-BM based assessment of lung cancer brain metastases after Gamma Knife therapy
Manpreet Kaur
08:00 AM - 09:00 AM EST Abstract 11-003 - An Efficient Approach to Mapping the Distribution of Renal Cell Carcinoma (RCC) Brain Metastases (BrM)
David O. Kamson, MD
08:00 AM - 09:00 AM EST Abstract 11-004 - CNS-Isolated Blast Crisis in A Patient with Chronic Myeloid Leukemia on Dasatinib
Benjamin J. Puccio, MD
08:00 AM - 09:00 AM EST Abstract 11-005 - Missing the Mark: CSF CA 19-9 secures diagnosis of rare Pancreatic Leptomeningeal Carcinomatosis
Sydnie Jones, MD
08:00 AM - 09:00 AM EST Abstract 11-006 - Outcomes of Patients with Neoplastic Meningitis Undergoing Ventriculoperitoneal Shunting and Intrathecal Chemotherapy, A Single Institution Retrospective Review
Amulya Gottiparthy, MD
Faculty Disclosures
Pavnit Kukreja, PharmD Dr. Kukreja has received personal compensation for serving as an employee of AbbVie. Dr. Kukreja has stock in AbbVie.
Gular Mammadli, MD Dr. Mammadli has nothing to disclose.
Koray Onuk Koray Onuk has nothing to disclose.
No disclosure on file
Anvita Potluri, MD Dr. Potluri has nothing to disclose.
Cynthia X. Wang, MD Dr. Wang has nothing to disclose.
Yasmine Saad No disclosure on file
Marshall Kirsch, DO Dr. Kirsch has nothing to disclose.
Fabio Nascimento, MD Dr. Nascimento has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zogenix. The institution of Dr. Nascimento has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. Dr. Nascimento has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Nascimento has received publishing royalties from a publication relating to health care. Dr. Nascimento has a non-compensated relationship as a Editorial Team Member with Neurology RFS that is relevant to AAN interests or activities. Dr. Nascimento has a non-compensated relationship as a Production Team with Neurology Podcast that is relevant to AAN interests or activities.
Jessica Ailani, MD, FAAN Dr. Ailani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan/Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GlaxoSmithKline. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gore. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scilex. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr. Reddy. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eneura. Dr. Ailani has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Report. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape. The institution of Dr. Ailani has received research support from Satsuma. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Medical Advisor with SELF.
Shruti P. Agnihotri, MD The institution of Dr. Agnihotri has received research support from Roche/ Genentech.
Jelena M. Pavlovic, MD, PhD Dr. Pavlovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven.
Amaal J. Starling, MD, FAAN Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Starling has received personal compensation in the range of $0-$499 for serving as a Consultant for Med-IQ. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Everyday Health. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Miller Medical. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eNeura.
Andrea Harriott, MD Dr. Harriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Harriott has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. The institution of Dr. Harriott has received research support from Electrocore. Dr. Harriott has a non-compensated relationship as a Author agreement with Abbvie that is relevant to AAN interests or activities. Dr. Harriott has a non-compensated relationship as a Researcher/Receipt of drug with Praxis that is relevant to AAN interests or activities.
Anna Marisa Cervantes-Arslanian, MD, FAAN Dr. Cervantes-Arslanian has nothing to disclose.
Mill Etienne, MD, MPH, FAAN Dr. Etienne has nothing to disclose.
Emily J. Gilmore, MD Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH.
Mahouba Frih MAHBOUBA FRIH has nothing to disclose.
Pilar Sanchez Alonso Pilar Sanchez Alonso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for zambon. Pilar Sanchez Alonso has received personal compensation in the range of $0-$499 for serving as a Consultant for Bial. Pilar Sanchez Alonso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for zambon. The institution of Pilar Sanchez Alonso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for abbvie. Pilar Sanchez Alonso has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for zambon. Pilar Sanchez Alonso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for bial. Pilar Sanchez Alonso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for novartis.
Tarek E. Ali, MBBS Dr. Ali has nothing to disclose.
Samantha De Gannes, MD Dr. De Gannes has nothing to disclose.
Teshamae Monteith, MD, FAAN Dr. Monteith has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LinPharma. Dr. Monteith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Global . Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Headache Society . Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for e-Neura. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as a Consultant for Merz. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alder. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alder. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva . Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN . The institution of Dr. Monteith has received research support from AbbVie. The institution of Dr. Monteith has received research support from Amgen. The institution of Dr. Monteith has received research support from Teva. The institution of Dr. Monteith has received research support from Electrocore. The institution of Dr. Monteith has received research support from Novartis . The institution of Dr. Monteith has received research support from Amgen. The institution of Dr. Monteith has received research support from lilly. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Education with Medscape. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Education with Massachusetts Medical Society . Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Education with Academic CME. Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Education with Rockpointe. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Neuodiem. Dr. Monteith has a non-compensated relationship as a President Elect with Florida Society of Neurology that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a Editorial Board with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a Board Member with International Headache Society that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Pfizer that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Abbvie that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Theranica that is relevant to AAN interests or activities.
Alison L. Christy, MD, PhD, FAAN Dr. Christy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity. Dr. Christy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishing. Dr. Christy has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDLinx. Dr. Christy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDLinx. The institution of Dr. Christy has received research support from Biohaven. The institution of Dr. Christy has received research support from Novartis / Amgen. The institution of Dr. Christy has received research support from Eli Lilly. The institution of Dr. Christy has received research support from Abbvie. The institution of Dr. Christy has received research support from Eli Lilly.
H. E. Hinson, MD, MCR, FAAN Dr. Hinson has received personal compensation in the range of $0-$499 for serving as a Consultant for Rapid AI. Dr. Hinson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Jinsy Andrews, MD, FAAN Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Cytokinetics. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revalasio . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AL-S Pharma. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quralis . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neurosense. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Akava. The institution of Dr. Andrews has received research support from Amylyx. The institution of Dr. Andrews has received research support from Biogen . The institution of Dr. Andrews has received research support from Cytokinetics . The institution of Dr. Andrews has received research support from NIH . The institution of Dr. Andrews has received research support from Biohaven/Platform Trial. The institution of Dr. Andrews has received research support from Clene/Platform Trial . The institution of Dr. Andrews has received research support from Ra Pharma/Platform Trial . The institution of Dr. Andrews has received research support from Prilenia/Platform Trial . Dr. Andrews has received research support from ALS Association . Dr. Andrews has a non-compensated relationship as a Board of Trustee Member with ALS Association that is relevant to AAN interests or activities.
Stephanie J. Nahas, MD, FAAN Dr. Nahas has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for AbbVie. Dr. Nahas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Nahas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tonix. Dr. Nahas has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Learning Network. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received publishing royalties from a publication relating to health care. Dr. Nahas has received personal compensation in the range of $500-$4,999 for serving as a expert/talent for CME event with Medscape/WebMD.
Jonathan Santoro, MD Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma.
George Plummer, MD Dr. Plummer has nothing to disclose.
Monica E. Loghin, MD Dr. Loghin has nothing to disclose.
James E. Siegler III, MD Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various medicolegal cases. The institution of Dr. Siegler has received research support from Viz.ai.
Shubham Misra, PhD Dr. Misra has nothing to disclose.
Meredith Hatcher, PA Mrs. Hatcher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Mrs. Hatcher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Mrs. Hatcher has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Shahin Hakimian, MD Dr. Hakimian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for OptumRx. Dr. Hakimian has stock in Various.
Anna J. Tomczak, MSc Miss Tomczak has nothing to disclose.
Jonathan Jagid No disclosure on file
Nizar Souayah, MD, FAAN Dr. Souayah has received publishing royalties from a publication relating to health care.
Kazim Jaffry Mr. Jaffry has nothing to disclose.
Lawrence J. Hirsch, MD, FAAN Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accure. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rafa Laboratories, Ltd. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a speaker with UCB.
Antonio M. Omuro, MD, FAAN Dr. Omuro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $0-$499 for serving as a Consultant for Kiyatec. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pyramid. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curevac. Dr. Omuro has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Opinion in Neurology. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Agios. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Denovo Biopharma.
Sonika Agarwal, MD, FAAN Dr. Agarwal has nothing to disclose.
M. B. Westover, MD, PhD Dr. Westover has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Beacon Biosignals. Dr. Westover has stock in Beacon Biosignals. The institution of Dr. Westover has received research support from NIH. Dr. Westover has received publishing royalties from a publication relating to health care. Dr. Westover has a non-compensated relationship as a cofounder with Beacon Biosignals that is relevant to AAN interests or activities.
Manpreet Kaur Miss Kaur has nothing to disclose.
Aimalohi Esechie, MD, PhD Dr. Esechie has nothing to disclose.
Lucas Horta, MD Dr. Horta has nothing to disclose.
Megan E. Trenz, DO Dr. Trenz has nothing to disclose.
Aaron F. Struck, MD The institution of Dr. Struck has received research support from Ceribell.
Victor Lami, MD Dr. Eslami has nothing to disclose.
Kejal Kantarci, MD The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF.
Dolly Reyes-Dumeyer No disclosure on file
Cristina Tassorelli Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dompè. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. The institution of Cristina Tassorelli has received research support from Abbvie.
Eric Anderson No disclosure on file
Stacey Clardy, MD, PhD, FAAN Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from Sumaira Foundation for NMO. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory.
Jennifer A. Kim, MD Dr. Kim has nothing to disclose.
Sarah B. Mulkey, MD, PhD The institution of Dr. Mulkey has received research support from Thrasher Research Fund. The institution of Dr. Mulkey has received research support from Centers of Disease Control. The institution of Dr. Mulkey has received research support from National Institutes of Health.
Michael S. Rafii, MD, PhD Dr. Rafii has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Dr. Rafii has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Keystone Bio. Dr. Rafii has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon.
Nupur N. Goel, MD Miss Goel has nothing to disclose.
Simona V. Proteasa, MD Dr. Proteasa has nothing to disclose.
Caroline B. Braune, MD Dr. Braune has nothing to disclose.
Badri Vardarajan Badri Vardarajan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kodikaz Therapeutics.
Abu Nasar No disclosure on file
Claire E. Delpirou Nouh, MD Dr. Delpirou Nouh has nothing to disclose.
Sukhraj Gill, MD Dr. Gill has nothing to disclose.
Nelitza I. Rivera Vega, MD Dr. Rivera Vega has nothing to disclose.
Shibeshih Belachew, MD Dr. Belachew has received personal compensation for serving as an employee of Biogen Inc. Dr. Belachew has received stock or an ownership interest from Biogen Inc.
Lisa T. Emrick, MD Dr. Emrick has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Arkema. The institution of Dr. Emrick has received research support from Lysogene. The institution of Dr. Emrick has received research support from PTC. The institution of Dr. Emrick has received research support from Roche. The institution of Dr. Emrick has received research support from NIH.
Mark Milstein, MD, FAAN Dr. Milstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Milstein has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various law firms. Dr. Milstein has received publishing royalties from a publication relating to health care. Dr. Milstein has a non-compensated relationship as a Board of Directors with New York County Medical Society that is relevant to AAN interests or activities.
Zubair Ahmed, MD Dr. Ahmed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ahmed has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Ahmed has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven.
Zain Guduru, MD, FAAN Dr. Guduru has nothing to disclose.
Aileen Antonio, MD, FAAN Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cochrane. Dr. Antonio has received research support from AAN PALF. The institution of Dr. Antonio has received research support from Trinity Health Foundation. The institution of Dr. Antonio has received research support from AAN IDEAS Grant. The institution of Dr. Antonio has received research support from Saint Mary's Foundation. The institution of Dr. Antonio has received research support from Saint Mary's Foundation . The institution of Dr. Antonio has received research support from Saint Mary's Foundation.
Salvatore Mazzeo Mr. Mazzeo has nothing to disclose.
Ramsey A. Falconer, MD Dr. Falconer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbott. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Falconer has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Amneal. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for GE Health. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Acorda. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. Dr. Falconer has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Federal Trade Comission (FTC). Dr. Falconer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Justice Department.
Shalane A. Morales-Nunez, MD Dr. Morales-Nunez has nothing to disclose.
Brooke Bloom, DO Dr. McNeilly has nothing to disclose.
Yoji Hoshina, MD Dr. Hoshina has nothing to disclose.
Catherine Najem, PhD Dr. Najem has received personal compensation for serving as an employee of Janssen R&D US.
Lauren Orda-Nguyen, NP Mrs. Orda-Nguyen has nothing to disclose.
Xiang Fang, MD, PhD, FAAN Dr. Fang has nothing to disclose.
Alberto J. Espay, MD, FAAN Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroderm. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Supernus (formerly, USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avion Pharmaceuticals. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Scott D. Newsome, DO, FAAN Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from The Stiff Person Syndrome Research Foundation. The institution of Dr. Newsome has received research support from Lundbeck. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Jonathan H. Smith, MD Dr. Smith has received personal compensation for serving as an employee of AbbVie. Dr. Smith has stock in AbbVie.
Marc R. Nuwer, MD, PhD, FAAN Dr. Nuwer has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Corticare. Dr. Nuwer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Several law firms. Dr. Nuwer has received research support from Second Sight. Dr. Nuwer has received publishing royalties from a publication relating to health care.
Roy H. Hamilton, MD, MS, FAAN Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Hamilton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highland Instruments. Dr. Hamilton has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for McKnight Brain Research Foundation. Dr. Hamilton has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology (Journal). The institution of Dr. Hamilton has received research support from NIH. The institution of Dr. Hamilton has received research support from Department of Defense. The institution of Dr. Hamilton has received research support from Chan Zuckerberg Initiative.
Brian L. Appavu, MD Dr. Appavu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Natus. The institution of Dr. Appavu has received research support from American Heart Association. The institution of Dr. Appavu has received research support from United States Department of Defense.
Nikki Win Nikki Win has received personal compensation for serving as an employee of Genentech. Nikki Win has stock in Genentech .
Sarah J. Meller, PhD Dr. Meller has received research support from National Institutes of Health Grant NIDCD F31DC018469-01.
Amaris Alayon, MD Ms. Alayon has nothing to disclose.
Dan Matlock No disclosure on file
Robert A. Bermel, MD, FAAN Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck Serono. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Joel Sullivan, DO Dr. Sullivan has nothing to disclose.
John R. Sollee Mr. Sollee has nothing to disclose.
Lixin Zhou Lixin Zhou has nothing to disclose.
Harry Zobel, Jr., DO Dr. Zobel has nothing to disclose.
Shefalika Prasad Ms. Prasad has nothing to disclose.
Corrado Bernasconi Corrado Bernasconi has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Roche. Corrado Bernasconi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GeNeuro. Corrado Bernasconi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera.
Sudipa Biswas, MD Dr. Biswas has nothing to disclose.
John T. Slevin, MD, FAAN Dr. Slevin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Slevin has received research support from Veterans Administration. The institution of Dr. Slevin has received research support from NIH. The institution of Dr. Slevin has received research support from AbbVie. The institution of Dr. Slevin has received research support from NeuroDerm. The institution of Dr. Slevin has received research support from Bukwang-Syneos. The institution of Dr. Slevin has received research support from Takeda.
Anthony Traboulsee, MD Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Genzyme.
Saud A. Sadiq, MD, MB, FAAN Dr. Sadiq has nothing to disclose.
Colm Elliott Colm Elliott has received personal compensation for serving as an employee of NeuroRx Research.
Rachel J. Saban, MD Dr. Saban has nothing to disclose.
Tomo Tarui, MD Dr. Tarui has nothing to disclose.
Anas A. Al-Khalili Mr. Al-Khalili has nothing to disclose.
Giulia Giacomucci Ms. Giacomucci has nothing to disclose.
Kameshwar Prasad, MD The institution of Prof. Prasad has received research support from Government of India Departments of Health Research and Biotechnology.
Irene Vavasour, PhD Dr. Vavasour has nothing to disclose.
Elisabetta Pagani No disclosure on file
Viviane T. Carvalho, MD Dr. Carvalho has nothing to disclose.
Axel M. Baez-Lugo, MD Dr. Baez-Lugo has nothing to disclose.
Stefan M. Pulst, MD, FAAN Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
Patrizia Pantano Patrizia Pantano has nothing to disclose.
Hussein Moussa, MD Dr. Moussa has nothing to disclose.
Afaaq Ahmed Mr. Ahmed has nothing to disclose.
Nico Paulo Dimal, MD Dr. Dimal has nothing to disclose.
Mor Gueye No disclosure on file
J. H. Harvey, DO Dr. Harvey has received personal compensation for serving as an employee of RSC Diagnostics. The institution of Dr. Harvey has received research support from GW Pharmaceuticals. The institution of Dr. Harvey has received research support from Cerevel Pharmaceuticals. The institution of Dr. Harvey has received research support from UCB Pharmaceuticals.
Gira I. Graciano, MD Dr. Graciano has nothing to disclose.
Sarah Doebley Miss Doebley has nothing to disclose.
Sudhindra Vooturi, PT Dr. Vooturi has nothing to disclose.
Rachel S. Choi Ms. Choi has nothing to disclose.
Tara Tripathi Sarkar No disclosure on file
Nicolò Tedone No disclosure on file
Manjari Tripathi, MD Dr. Tripathi has nothing to disclose.
Burcu Zeydan, MD The institution of Dr. Zeydan has received research support from National Institutes of Health.
Ryan Kammeyer, MD The institution of Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ogborn-Mihm Trial Lawyers. The institution of Dr. Kammeyer has received research support from Rocky Mountain Multiple Sclerosis Center.
Timothy R. Smith, MD The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vorso/Nesos. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alder/Lundbeck. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurolief. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie/Allergan. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Smith has stock in United Health Group. The institution of Dr. Smith has received research support from Aeon. The institution of Dr. Smith has received research support from Alder/Lundbeck. The institution of Dr. Smith has received research support from Alnylam. The institution of Dr. Smith has received research support from Amgen. The institution of Dr. Smith has received research support from Abbvie/Allergan. The institution of Dr. Smith has received research support from Biohaven. The institution of an immediate family member of Dr. Smith has received research support from Eliem Pharmaceuticals. The institution of Dr. Smith has received research support from Lilly. The institution of Dr. Smith has received research support from Pfizer. The institution of Dr. Smith has received research support from Nocira. The institution of Dr. Smith has received research support from Novo Nordisk. The institution of Dr. Smith has received research support from Teva. The institution of Dr. Smith has received research support from Theranica. The institution of Dr. Smith has received research support from Vorso/Nesos. Dr. Smith has a non-compensated relationship as a Board Member with National Headache Foundation that is relevant to AAN interests or activities.
Zahra Haghighat, MD Dr. Haghighat has nothing to disclose.
Jaime Toro, MD, FAAN Dr. Toro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Watch Neurology .
David O. Kamson, MD The institution of Dr. Kamson has received research support from Maryland Cigarette Restitution Fund.
Dongliang Wang No disclosure on file
Anjali Kamath An immediate family member of Miss Kamath has received personal compensation for serving as an employee of Abbvie Pharmaceuticals. An immediate family member of Miss Kamath has received personal compensation for serving as an employee of Abbvie Pharmaceuticals. An immediate family member of Miss Kamath has stock in Biocryst Pharmaceuticals. An immediate family member of Miss Kamath has stock in Abbvie Pharmaceuticals.
Kan Ding, MD The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Yi-Cheng Zhu, MD, PhD Dr. Zhu has nothing to disclose.
Robert Croop, MD Dr. Croop has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Dr. Croop has received personal compensation for serving as an employee of Pfizer Inc.. Dr. Croop has stock in Biohaven Pharmaceutical Holding Co Ltd. Dr. Croop has stock in Biohaven Ltd.. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care.
Simrika Thapa, PhD Dr. Thapa has nothing to disclose.
Christopher J. Whiting, DO Dr. Whiting has nothing to disclose.
Loredana Storelli Loredana Storelli has nothing to disclose.
Satoshi Kitagawa No disclosure on file
Thor D. Stein, MD, PhD Dr. Stein has nothing to disclose.
Leon Jekel Mr. Jekel has nothing to disclose.
Fnu Rameez, MBBS Dr. Rameez has nothing to disclose.
Kaj Blennow No disclosure on file
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi;. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi- Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Marina Sarno, Other Dr. Sarno has nothing to disclose.
Srinath Ramaswamy, MD Dr. Ramaswamy has nothing to disclose.
Masahiro Jinzaki No disclosure on file
Lina Patel No disclosure on file
Dana Klavansky, MD Dr. Klavansky has nothing to disclose.
Shannon Kolind, PhD, MSc, BSc Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Kolind has received research support from Sanofi Genzyme. The institution of Dr. Kolind has received research support from Roche. The institution of Dr. Kolind has received research support from Biogen.
Shravan Sivakumar, MBBS Dr. Sivakumar has nothing to disclose.
Muhammad Taimur A. Malik, MD Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech . Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen . Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD serono. The institution of Dr. Malik has received research support from National MS Society .
Gabriela T. Gomez Ms. Gomez has nothing to disclose.
Michael Walsh, Other Mr. Walsh has nothing to disclose.
Sarah Woidill No disclosure on file
Hemani Ticku, MD Dr. Ticku has nothing to disclose.
Lauren Gluck, MD Dr. Gluck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen.
David Q. Beversdorf, MD, FAAN Dr. Beversdorf has received personal compensation in the range of $0-$499 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Human Biosciences. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Neuropharma. Dr. Beversdorf has received personal compensation in the range of $0-$499 for serving as a Consultant for Stalicla. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scioto. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from BionexusKC. The institution of Dr. Beversdorf has received research support from Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $10,000-$49,999 for serving as a Case Consultant with Best Doctors.
Heitor Cabral Frade, MD Dr. Cabral Frade has nothing to disclose.
Puneet Uppal No disclosure on file
Kazuko Hasegawa, MD Dr. Hasegawa has nothing to disclose.
Ivy Gao Miss Gao has nothing to disclose.
Laura J. Wu, MD, PhD Dr. Wu has nothing to disclose.
Terry D. Heiman-Patterson, MD Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ITF. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samus. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylym. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics.
Judith E. Warner, MD Dr. Warner has received intellectual property interests from a discovery or technology relating to health care.
Fatma Yesim Parman, MD Dr. Parman has nothing to disclose.
Holly A. Shill, MD, FAAN Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc.
Ihtsham Haq, MD, FAAN The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation. The institution of Dr. Haq has received research support from NIMH. Dr. Haq has a non-compensated relationship as a consultant with Medtronics that is relevant to AAN interests or activities. Dr. Haq has a non-compensated relationship as a consultant with Boston Scientific that is relevant to AAN interests or activities. Dr. Haq has a non-compensated relationship as a consultant with Abbott that is relevant to AAN interests or activities.
Alfonso Fasano, MD, PhD, FAAN Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. Dr. Fasano has received publishing royalties from a publication relating to health care.
Wallace Brownlee, MD Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage.
Melissa Reider-Demer, DNP, MN, CNP Dr. Reider-Demer has nothing to disclose.
Vaishnavi L. Vaidyanathan, MD Dr. Vaidyanathan has nothing to disclose.
Aaron Zelikovich, MD Dr. Zelikovich has nothing to disclose.
Yuyao Sun, MD Dr. Sun has nothing to disclose.
Erin S. Beck, MD The institution of Dr. Beck has received research support from National Multiple Sclerosis Society. Dr. Beck has received intellectual property interests from a discovery or technology relating to health care.
Fenwick T. Nichols III, MD, FAAN Dr. Nichols has nothing to disclose.
Nabeel Ahmed Mr. Ahmed has nothing to disclose.
Eufrosina I. Young, MD The institution of Dr. Young has received research support from Mitsubishi Tanabe Pharma America.
Mustafa Jaffry Mr. Jaffry has nothing to disclose.
Carlos Alva-Diaz No disclosure on file
Ding-Ding Zhang No disclosure on file
Ajay Rajshekar, DO Dr. Rajshekar has nothing to disclose.
Claudia Cruzalegui Bazán Miss Cruzalegui Bazán has nothing to disclose.
Nur Neyal, MD Dr. Neyal has nothing to disclose.
Aarti Sarwal, MD, FAAN Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stimdia, Inc. Dr. Sarwal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Critical Care Medicine. The institution of Dr. Sarwal has received research support from Butterfly, Inc. The institution of Dr. Sarwal has received research support from Bard. The institution of Dr. Sarwal has received research support from Biogen. The institution of Dr. Sarwal has received research support from Novartis. The institution of Dr. Sarwal has received research support from CVR Global. The institution of Dr. Sarwal has received research support from NIH/NIA R01 AG066910-01 . The institution of Dr. Sarwal has received research support from Image Monitoring. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Faculty, CME courses with Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Intensive Care Society. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Indian Society of Critical Care. Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Subject expert for thesis review with UNIVERSITY OF TECHNOLOGY . Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Research participation in clinical trial funded by AHRQ with MEDSTAR HEALTH RESEARCH INSTITUTE . Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a speaker/Faculty for Annual meeting, travel compensation with European Society of Intensive Care Medicine. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME event with Thomas Jefferson University . Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Pittsburgh. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ISICEM. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Associate Editor, Clinical Neuroimaging with American Society of Neuroimaging . Dr. Sarwal has a non-compensated relationship as a Social Media Editor with Neurocritical Care that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Board of Directors with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a President with Association of Indian Neurologists in America that is relevant to AAN interests or activities.
Jun Ni No disclosure on file
Garrett M. Friedman, MD Dr. Friedman has nothing to disclose.
Anand V. Patel, MD Dr. Patel has nothing to disclose.
Claudia M. Prospero Ponce, MD Dr. Prospero Ponce has nothing to disclose.
Federico Casale No disclosure on file
Michael Grunstein, DO Dr. Grunstein has nothing to disclose.
Bonnie E. Levin, PhD No disclosure on file
Muhammad Z. Memon, MD Dr. Memon has nothing to disclose.
Amira Salim Miss Salim has nothing to disclose.
Walter G. Husar, MD Dr. Husar has nothing to disclose.
Anuja R. Patil, MD, DM Dr. Patil has nothing to disclose.
Vikram Prakash, MD Dr. Prakash has nothing to disclose.
Amanda Persaud, MD Dr. Persaud has nothing to disclose.
Darshini Shah, Other Ms. Shah has received personal compensation for serving as an employee of AbbVie. Ms. Shah has stock in AbbVie Inc. An immediate family member of Ms. Shah has received research support from National Institutes of Health.
Joshua Nahm No disclosure on file
Doug Gunzler No disclosure on file
Ayah Al-Bzour Miss Al-Bzour has nothing to disclose.
Nevin A. John, MBBS Dr. John has nothing to disclose.
Andrea Pardo, MD The institution of Dr. Pardo has received research support from UCB Biosciences. The institution of Dr. Pardo has received research support from The Patrick G. and Shirley W. Ryan Foundation . The institution of Dr. Pardo has received research support from NINDS- Stroke Trials Network. The institution of Dr. Pardo has received research support from NINDS-I-ACQUIRE. The institution of Dr. Pardo has received research support from NINDS- VIPS-II.
Grace Gombolay, MD Dr. Gombolay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pediatric Neurology. An immediate family member of Dr. Gombolay has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Washington Injury Lawyers. The institution of Dr. Gombolay has received research support from CDC. The institution of Dr. Gombolay has received research support from NIH.
Hashem M. Shaltoni, MD Dr. Shaltoni has nothing to disclose.
Peter A. Calabresi, MD, FAAN Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Yorghos Tripodis No disclosure on file
Ankit Pahwa Ankit Pahwa has nothing to disclose.
Michael D. Weiss, MD, FAAN Dr. Weiss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB-RA. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Weiss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Soleo. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Christopher Schwarz No disclosure on file
Peter C. Dowling, MD No disclosure on file
Jiangyong Min, MD Dr. Min has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott . Dr. Min has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic .
Siegfried Hirczy, MD An immediate family member of Dr. Hirczy has received personal compensation for serving as an employee of Meta. Dr. Hirczy has received personal compensation in the range of $500-$4,999 for serving as a Author with Slack Enterprises.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Russell D'Aiello No disclosure on file
Jonadab Dos Santos Silva Mr. Dos Santos Silva has nothing to disclose.
Julia See Miss See has nothing to disclose.
Michael Alosco, PhD The institution of Michael Alosco, PHD has received research support from NIH.
Alexander Bolufer Mr. Bolufer has nothing to disclose.
Michael C. Kruer, MD The institution of Dr. Kruer has received research support from NIH NINDs. Dr. Kruer has received research support from Cure CP. Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with NHRSA.
Muhib Khan, MD, FAAN The institution of Dr. Khan has received research support from NINDS. The institution of Dr. Khan has received research support from Genentech. The institution of Dr. Khan has received research support from Spectrum Health-MSU alliance. Dr. Khan has received research support from NIH.
Rajeev Kumar, MD, FRCPC The institution of Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Teva Pharmaceuticals. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda Therapeutics. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevel Therapeutics. Dr. Kumar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel Pharma. Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda Therapeutics. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Research Catalyst, LLC. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for CenExel RMCR. Dr. Kumar has stock in Research Catalyst, LLC. Dr. Kumar has stock in CenExel. The institution of Dr. Kumar has received research support from Supernus. The institution of Dr. Kumar has received research support from Sage Therapeutics. The institution of Dr. Kumar has received research support from Prilenia Therapeutics. The institution of Dr. Kumar has received research support from Roche. The institution of Dr. Kumar has received research support from Triplet Therapeutics. The institution of Dr. Kumar has received research support from CHDI Foundation. The institution of Dr. Kumar has received research support from Neurocrine Biosciences. The institution of Dr. Kumar has received research support from Biovie. The institution of Dr. Kumar has received research support from Neuroderm. The institution of Dr. Kumar has received research support from Sanofi. The institution of Dr. Kumar has received research support from Addex Pharma. The institution of Dr. Kumar has received research support from Integrative Research Laboratories. The institution of Dr. Kumar has received research support from Takeda Pharmaceuticals. The institution of Dr. Kumar has received research support from Neuraly. The institution of Dr. Kumar has received research support from Abbvie. The institution of Dr. Kumar has received research support from Cerevel Therapeutics. The institution of Dr. Kumar has received research support from Transposon Therapeutics. The institution of Dr. Kumar has received research support from Lundbeck. The institution of Dr. Kumar has received research support from Biohaven. The institution of Dr. Kumar has received research support from Revance Therapeutics. The institution of Dr. Kumar has received research support from Impax Laboratories. The institution of Dr. Kumar has received research support from Pharma Two B. The institution of Dr. Kumar has received research support from Enterin. The institution of Dr. Kumar has received research support from CND Life Sciences. The institution of Dr. Kumar has received research support from Neuron23. The institution of Dr. Kumar has received research support from Annexon Biosciences. The institution of Dr. Kumar has received research support from Annovis. The institution of Dr. Kumar has received research support from PTC Therapeutics. The institution of Dr. Kumar has received research support from Uniqure. The institution of Dr. Kumar has received research support from Alexza. The institution of Dr. Kumar has received research support from SparkNeuro. The institution of Dr. Kumar has received research support from Praxis. The institution of Dr. Kumar has received research support from Scion Neurostim. The institution of Dr. Kumar has received research support from Cognition Therapeutics. The institution of Dr. Kumar has received research support from Eli Lilly. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Medical Director with CenExel RMCR. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as a Managing Member with Research Catalyst, LLC.
Natalia Bohorquez Morera Natalia Bohorquez Morera has nothing to disclose.
Calvin Hu, MD Dr. Hu has nothing to disclose.
Gioacchino Tedeschi, MD Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Stephen Jaworski, MD Dr. Jaworski has nothing to disclose.
Nathaniel J. Mohney, MD The institution of Dr. Mohney has received research support from NIH.
Scott Husak No disclosure on file
Maurice Driessen No disclosure on file
Wim Noel No disclosure on file
Lyubov Rubin, MD Dr. Rubin has nothing to disclose.
Paola Valsasina No disclosure on file
Rana Hanna AL-Shaikh, MD Dr. Hanna AL-Shaikh has nothing to disclose.
Jamie N. Lehnen Ms. Lehnen has nothing to disclose.
Jenny Meyer, MD The institution of Dr. Meyer has received research support from Grifols. The institution of Dr. Meyer has received research support from Medicinova.
Steven Kymes Steven Kymes has received personal compensation for serving as an employee of Lundbeck. Steven Kymes has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Ophthalmology. Steven Kymes has received research support from Emmes Corporation.
Carmen Vizzino No disclosure on file
Ammar I. Hamza, MD Mr. Hamza has nothing to disclose.
Thomas E. Ragole, MD The institution of Dr. Ragole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. The institution of Dr. Ragole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Ragole has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. The institution of Dr. Ragole has received research support from Alexion Pharmaceuticals.
Tritia R. Yamasaki, MD, PhD, FAAN The institution of Dr. Yamasaki has received research support from Veteran's Affairs. The institution of an immediate family member of Dr. Yamasaki has received research support from Dept of Energy.
Melanie Boly, MD Dr. Boly has nothing to disclose.
Steven Tyler No disclosure on file
Niki Holtzman-Hayes, MD Dr. Holtzman-Hayes has nothing to disclose.
Ahmed A. Bayoumi Mr. Bayoumi has nothing to disclose.
Amy Lavery No disclosure on file
Connie H. Yan, PhD, PharmD Dr. Yan has received personal compensation for serving as an employee of AbbVie Inc. Dr. Yan has stock in AbbVie Inc.
Steven A. Gunzler, MD, FAAN Dr. Gunzler has received research support from NIH/NINDS. The institution of Dr. Gunzler has received research support from Biogen. The institution of Dr. Gunzler has received research support from Amneal. Dr. Gunzler has received research support from Michael J Fox Foundation.
Brian M. Sauer, MD Dr. Sauer has nothing to disclose.
Lisa Christopher-Stine, MD, MPH No disclosure on file
Juliana Nitis Ms. Nitis has nothing to disclose.
Carlos Rodrigo Q. Vicuña Mr. Vicuña has nothing to disclose.
Irene Dixe de Oliveira Santo, MD Dr. Dixe de Oliveira Santo has nothing to disclose.
Hannah M. Bullock Ms. Bullock has nothing to disclose.
Erika Shelton No disclosure on file
Fardin Nabizadeh III Mr. Nabizadeh has nothing to disclose.
Dawn L. Gano, MD Dr. Gano has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Clifford Law Offices. The institution of Dr. Gano has received research support from Cerebral Palsy Alliance Research Foundation.
Jaroslaw Dulski, MD, PhD Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VM Media Ltd.. Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Radoslaw Lipinski 90 Consulting. Dr. Dulski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Dulski has received research support from Polish Neurological Society. Dr. Dulski has received research support from Polish National Agency for Academic Exchange. Dr. Dulski has received intellectual property interests from a discovery or technology relating to health care.
Meagen Salinas, MD The institution of Dr. Salinas has received research support from North Texas VA Health Care System New Investigator Award.
Yaacov Anziska, MD Dr. Anziska has nothing to disclose.
Emanuele Koumantakis No disclosure on file
Mariam Aboian, MD, PhD Dr. Aboian has a non-compensated relationship as a Principal Investigator with Visage Imaging that is relevant to AAN interests or activities.
Rebekah M. Ahmed, MD Dr. Ahmed has nothing to disclose.
Luiza Lima, MD Dr. Lima has nothing to disclose.
Esther H. Nie, PhD Dr. Nie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medidata, Acorn AI. The institution of Dr. Nie has received research support from Roche/Genentech.
Henrik Ehrhardt, MBBCh Henrik Ehrhardt has nothing to disclose.
Klepper A. Garcia, MD Dr. Garcia has nothing to disclose.
Alexandra S. Reynolds, MD Dr. Reynolds has nothing to disclose.
Yaman Ahmed Mr. Ahmed has nothing to disclose.
Neeharika Thottempudi, MD Dr. Thottempudi has nothing to disclose.
Joseph Y. Yoon, MD Dr. Yoon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ECHAS.
James F. Sumowski Mr. Sumowski has nothing to disclose.
Jesse B. Mez, MD The institution of Dr. Mez has received research support from NIH, DOD.
Yilun Chen Ms. Chen has nothing to disclose.
Sindhu Ramchandren, MD Dr. Ramchandren has received personal compensation for serving as an employee of Janssen Pharmaceutical Companies of Johnson & Johnson. Dr. Ramchandren has a non-compensated relationship as a Scientific Advisory Board Member with CMT Research Foundation (CMTRF) that is relevant to AAN interests or activities.
Benjamin Malinda Mr. Malinda has nothing to disclose.
Jennifer Bain, MD, PhD Dr. Bain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Bain has received personal compensation in the range of $0-$499 for serving as a Consultant for M3 Consulting. Dr. Bain has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Legal Company . Dr. Bain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grin Therapeutics. Dr. Bain has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for New York University. Dr. Bain has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for SUNY Donwstate. The institution of Dr. Bain has received research support from Yellow Brick Road Project. The institution of Dr. Bain has received research support from To Cure a Rose Foundation.
Jairo A. Gaitan Alfonso, MD Dr. Gaitan Alfonso has nothing to disclose.
Adriano Chio, MD, FAAN Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen.
Laura A. Adang, MD Dr. Adang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Development Center Americas, Inc.. Dr. Adang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Middle East Genetics and Metabolic Academy (MEGMA).
Junpeng Zhuang Dr. Zhuang has received personal compensation for serving as an employee of Eli Lilly.
Sahil Kapoor No disclosure on file
Runi Tanna Miss Tanna has nothing to disclose.
Asako Takanohashi, PhD, DVM Dr. Takanohashi has nothing to disclose.
Elizabeth G. Baumann, MD Dr. Baumann has nothing to disclose.
Yvonne Hao Miss Hao has nothing to disclose.
Judy Van De Water Judy Van De Water has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MARAbio. Judy Van De Water has stock in MARAbio. Judy Van De Water has received intellectual property interests from a discovery or technology relating to health care.
Michael A. Connerney, MD Dr. Connerney has nothing to disclose.
Scott Harcourt, PhD Dr. Harcourt has nothing to disclose.
Giulia S. Porcari, MD Dr. Porcari has nothing to disclose.
Patrick M. Kwon, MD Dr. Kwon has nothing to disclose.
Aaron M. Carlson, MD Dr. Carlson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Carlson has received research support from Horizon Therapeutics. Dr. Carlson has a non-compensated relationship as a Health Service Subcommittee Member with American Academy of Neurology that is relevant to AAN interests or activities.
Inna Keselman, MD, PhD Dr. Keselman has nothing to disclose.
Michelle Fullard, MD Dr. Fullard has received research support from Davis Phinney Foundation. Dr. Fullard has received research support from Michael J. Fox Foundation. The institution of Dr. Fullard has received research support from NIH BIRCWH K12. Dr. Fullard has received research support from Lorna G. Moore Faculty Launch Fund.
Jessalyn Shen, MD Dr. Shen has nothing to disclose.
Lucia Moiola, MD, PhD Dr. Moiola has nothing to disclose.
Seema Soni-Brahmbhatt Seema Soni-Brahmbhatt has nothing to disclose.
Lars Viktrup No disclosure on file
Tatiana Greige, MD Dr. Greige has nothing to disclose.
Manan Shah, MD, MBBS Dr. Shah has nothing to disclose.
Carlton Anderson, PhD Mr. Anderson has nothing to disclose.
Nicholas Lannen, MD Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genentech. Dr. Lannen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for TG Therapeutics. Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Horizon Theraputics.
Jeffrey E. Dunn, MD, FAAN Dr. Dunn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Dunn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Dunn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Dunn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. The institution of Dr. Dunn has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Progentec Diagnostics.
Yamuna Joseph No disclosure on file
Leah P. Dickstein, MD Dr. Dickstein has nothing to disclose.
Grigorios Kalaitzidis, MD Mr. Kalaitzidis has nothing to disclose.
Lucas Kipp, MD The institution of Dr. Kipp has received research support from Biogen. The institution of Dr. Kipp has received research support from Genentech.
Mark S. Scher, MD Dr. Scher has nothing to disclose.
Anam K. Shaikh Miss Shaikh has nothing to disclose.
Justin Kinsella, MD Dr. Kinsella has nothing to disclose.
Anna Vasilevskaya, PhD Anna Vasilevskaya has nothing to disclose.
Jeffrey Dage, PhD Dr. Dage has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Dage has stock in Eli Lilly and Company. Dr. Dage has stock in General Electric. Dr. Dage has received research support from Indiana University School Of Medicine. Dr. Dage has received intellectual property interests from a discovery or technology relating to health care.
Adam Brickman, PhD Adam Brickman, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognition Therapeutics.
John Thomson, PhD Dr. Thomson has received personal compensation for serving as an employee of Wren Therapeutics. Dr. Thomson has received intellectual property interests from a discovery or technology relating to health care. Dr. Thomson has received intellectual property interests from a discovery or technology relating to health care.
Ajay Garg No disclosure on file
Jonathan Rosenthal, MD Dr. Rosenthal has nothing to disclose.
Lauren Nelson, MD Dr. Nelson has nothing to disclose.
Yingyi Liu No disclosure on file
Tae Jin Park Mr. Park has received personal compensation for serving as an employee of AbbVie. Mr. Park has stock in AbbVie.
Bryan Cobb, PhD, FACMGG Dr. Cobb has received personal compensation for serving as an employee of Genentech. Dr. Cobb has stock in Roche. Dr. Cobb has received intellectual property interests from a discovery or technology relating to health care.
Prasanna Gangishetti, MBBS Dr. Gangishetti has nothing to disclose.
Oralee J. Varnado, PhD Miss Varnado has received personal compensation for serving as an employee of Eli Lilly and Company. Miss Varnado has stock in Eli Lilly and Company.
Chloe Anastassiadis Ms. Anastassiadis has received research support from Fonds de Recherche du Québec - Santé (FRQS).
Hiba Naveed, MD Ms. Naveed has nothing to disclose.
Christopher Jensen, PharmD Dr. Jensen has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Jensen has stock in Biohaven Pharmaceuticals.
Sylvia Josephy, MD Dr. Josephy has nothing to disclose.
Gabriel Rodriguez Gabriel Rodriguez has nothing to disclose.
Caroline Goldin, MD Dr. Goldin has nothing to disclose.
Kranthi K. Mandava Mr. Mandava has nothing to disclose.
H. A. Jinnah, MD, PhD, FAAN Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takaha/Ene. Dr. Jinnah has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Jinnah has received research support from Addex. The institution of Dr. Jinnah has received research support from Aeon. The institution of Dr. Jinnah has received research support from Revance. The institution of Dr. Jinnah has received research support from Jazz.
Aybuke Acar, MD Dr. Acar has nothing to disclose.
Nour N. Al-Bzour Miss Al-Bzour has nothing to disclose.
Ahmed Harazeen, MBBS Dr. Harazeen has nothing to disclose.
Hirokazu Fujiwara No disclosure on file
Rohit Aggarwal, MD Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kezar. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenex. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BI. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Q32. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Corbus. Dr. Aggarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. The institution of Dr. Aggarwal has received research support from Genentech. The institution of Dr. Aggarwal has received research support from Mallinckodt. The institution of Dr. Aggarwal has received research support from BMS. The institution of Dr. Aggarwal has received research support from EMD Serono. The institution of Dr. Aggarwal has received research support from Q32.
Eduardo Inacio Nascimento Andrade, MD Dr. Nascimento Andrade has nothing to disclose.
Arie Gafson, MD, PhD Dr. Gafson has stock in Biogen.
Zabeen K. Mahuwala, MD, FAAN Dr. Mahuwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. The institution of Dr. Mahuwala has received research support from UCB, . The institution of Dr. Mahuwala has received research support from Alexion . The institution of Dr. Mahuwala has received research support from argenx . The institution of Dr. Mahuwala has received research support from immunovant.
Kathryn Fitzgerald, PhD The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society.
Benedetta Nacmias Benedetta Nacmias has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Paul V. Motika, MD Dr. Motika has nothing to disclose.
Ming Yao No disclosure on file
Andrew M. Nguyen, MD Dr. Nguyen has nothing to disclose.
Melanie Manning No disclosure on file
Siddharth Dalal, MD Dr. Dalal has nothing to disclose.
Jin Nakahara, MD, PhD Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Prof. Nakahara has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai. Prof. Nakahara has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Mitsubishi-Tanabe. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi-Sankyo. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Prof. Nakahara has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Japanese Society for Internal Medicine. The institution of Prof. Nakahara has received research support from EA Pharma. The institution of Prof. Nakahara has received research support from JB. The institution of Prof. Nakahara has received research support from Eisai. The institution of Prof. Nakahara has received research support from Shionogi. The institution of Prof. Nakahara has received research support from Boehringer Ingelheim. The institution of Prof. Nakahara has received research support from Kyowa Kirin. The institution of Prof. Nakahara has received research support from Sumitomo Pharma. The institution of Prof. Nakahara has received research support from Otsuka. The institution of Prof. Nakahara has received research support from Chugai. The institution of Prof. Nakahara has received research support from Teijin. The institution of Prof. Nakahara has received research support from Mitsubishi-Tanabe.
Monica Lemmon, MD Dr. Lemmon has received research support from NINDS. Dr. Lemmon has received research support from BAND foundation. Dr. Lemmon has received research support from Doris Duke Charitable Foundation. Dr. Lemmon has received research support from Child Neurology Society.
Emily Sergio, Other Ms. Sergio has nothing to disclose.
Ivanna Joseph, MD Dr. Joseph has nothing to disclose.
Erafat Rehim, MD Dr. Rehim has nothing to disclose.
Vanessa Salej, MD Dr. Salej has nothing to disclose.
May Han, MD Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Han has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arena Pharmaceuticals.
Vanessa C. Colares Lessa, MD Dr. Colares Lessa has nothing to disclose.
Lawrence S. Honig, MD, PhD, FAAN Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Honig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Honig has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Dr. Honig has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Firms . The institution of Dr. Honig has received research support from Roche. The institution of Dr. Honig has received research support from Eisau. Dr. Honig has received research support from Alector. The institution of Dr. Honig has received research support from Transposon.
Amy T. Waldman, MD Dr. Waldman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio. An immediate family member of Dr. Waldman has stock in Pfizer. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. Dr. Waldman has received publishing royalties from a publication relating to health care.
Gabriel R. Arismendi, MD Dr. Arismendi has nothing to disclose.
Christopher Lock, MD, MBBS, PhD Dr. Lock has received personal compensation for serving as an employee of InterX Inc. Dr. Lock has received personal compensation for serving as an employee of Diagnose Early . Dr. Lock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Lock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi . Dr. Lock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono . Dr. Lock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Lock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. Dr. Lock has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lock has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for OGLE, WORM & TRAVIS, PLLP.
Bert B. Vargas, MD, FAAN Dr. Vargas has received personal compensation for serving as an employee of Lilly USA. Dr. Vargas has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ElevateMed. Dr. Vargas has stock in Eli Lilly. An immediate family member of Dr. Vargas has stock in Pfizer. Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Unaffiliated Neurotrauma Consultant with National Football League. Dr. Vargas has received personal compensation in the range of $10,000-$49,999 for serving as a Neurotrauma Consultant with National Association for Stock Car Auto Racing.
Alexandra Seide Cardoso, MD Dr. Seide Cardoso has nothing to disclose.
Daniel Kaganovich Daniel Kaganovich has received personal compensation for serving as an employee of Wren Therapeutics.
Camelia Valhuerdi Porto, MD Dr. Valhuerdi Porto has nothing to disclose.
Jerry Chen, MD Dr. Chen has nothing to disclose.
Nicola De Stefano, MD Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Healthcare KGaA. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono S.p.A. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche S.p.A.. The institution of Dr. De Stefano has received research support from Italian MS Society. The institution of Dr. De Stefano has received research support from Merck Healthcare KGaA.
Ann C. McKee, MD Dr. McKee has nothing to disclose.
Nancy Song, MD Dr. Song has nothing to disclose.
Anisha Patel, PhD Dr. Patel has received personal compensation for serving as an employee of Genentech. An immediate family member of Dr. Patel has received personal compensation for serving as an employee of Google. Dr. Patel has stock in Genentech Inc.. An immediate family member of Dr. Patel has stock in Google.
Julia R. Schneider, DO Dr. Schneider has nothing to disclose.
Elena Monai, MD Dr. Monai has nothing to disclose.
Michelle D. DeJesus Brazitis, MD Dr. DeJesus Brazitis has nothing to disclose.
Emily Zivin No disclosure on file
Maya Pandit, MPH Ms. Pandit has nothing to disclose.
Ling Ling Rong, MD Dr. Rong has nothing to disclose.
Stewart J. Tepper, MD Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cleaview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Medical Comm. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Education Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' Education Resource. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical Education. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview.
Sindhura Tadisetty Mrs. Tadisetty has nothing to disclose.
Allison R. Valerius, MD Dr. Valerius has nothing to disclose.
Hassnain A. Rizvi, DO Dr. Rizvi has nothing to disclose.
Alexander Sherman The institution of Mr. Sherman has received research support from The ALS Association. The institution of Mr. Sherman has received research support from NIH. The institution of Mr. Sherman has received research support from FDA. The institution of Mr. Sherman has received research support from Biogen. The institution of Mr. Sherman has received research support from Amylyx Pharmaceuticals. The institution of Mr. Sherman has received research support from Mitsubishi-Tanabe Pharma America. Mr. Sherman has a non-compensated relationship as a Member, Board of Directors with ALD Connect that is relevant to AAN interests or activities.
Yun-Beom Choi, MD, PhD The institution of Dr. Choi has received research support from Department of Veterans Affairs.
Frederik Barkhof, MD, PhD Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Jorge Zamudio, MD, MBA Dr. Zamudio has received personal compensation for serving as an employee of Abbvie. Dr. Zamudio has received personal compensation for serving as an employee of Abbvie. Dr. Zamudio has received stock or an ownership interest from Abbvie .
Carolina Parker, MD Dr. Parker has nothing to disclose.
Gustavo Schafascheck, MD Dr. Schafascheck has nothing to disclose.
Taylor R. Anderson, MD Dr. Anderson has nothing to disclose.
Alex Berger, BS Mr. Berger has nothing to disclose.
Stephane Regnier, PhD Mr. Regnier has received personal compensation for serving as an employee of Lundbeck. Mr. Regnier has received personal compensation for serving as an employee of Novartis. Mr. Regnier has stock in Novartis.
Ashley Dafoe No disclosure on file
Neda Sattarnezhad Oskouei, MD Dr. Sattarnezhad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD-Serono. Dr. Sattarnezhad has received research support from National MS Society.
Koji Sekiguchi No disclosure on file
Julia Sumera Miss Sumera has nothing to disclose.
Stefano Magon No disclosure on file
Zaza Katsarava, MD Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Jeremy S. Chataway, MD Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NerveGen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Matteo Locatelli, BS Mr. Locatelli has nothing to disclose.
Sean T. Kenniff, MD Dr. Kenniff has nothing to disclose.
Gabriele Mora, MD Dr. Mora has nothing to disclose.
Nilufer Yalcin, MD Dr. Yalcin has nothing to disclose.
Justine Shults No disclosure on file
Richard P. Mayeux, MD, MSc, FAAN Dr. Mayeux has nothing to disclose.
Paolo Preziosa Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Robert A. Nicholson, PhD Dr. Nicholson has received personal compensation for serving as an employee of Eli Lilly & Company. Dr. Nicholson has stock in Eli Lilly & Company. Dr. Nicholson has received intellectual property interests from a discovery or technology relating to health care.
Jonathan Schott, MD, FRCP, FEAN, FAAN Dr. Schott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alzheimer's Research UK. Dr. Schott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UK Dementia Research Institute. Dr. Schott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Schott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GE. Dr. Schott has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press.
Walter Faig No disclosure on file
Alessandro Di Rocco, MD Dr. Di Rocco has nothing to disclose.
Joon-Shik Moon, MD Dr. Moon has nothing to disclose.
Chetan Nayak, MD Dr. Nayak has nothing to disclose.
Julie A. Gurwell, PhD, PA-C Dr. Gurwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Gurwell has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology . The institution of Dr. Gurwell has received research support from University of Kentucky Brain Restoration Center. The institution of Dr. Gurwell has received research support from University of Kentucky Department of Neurology Pilot Grant. Dr. Gurwell has received personal compensation in the range of $500-$4,999 for serving as a speaker at the annual CME meeting with Kentucky Academy of Physician Assistants.
Ivonne Suridjan No disclosure on file
Jay-Jiguang Zhu, MD, PhD, FAAN Dr. Zhu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure, INC, Japan. An immediate family member of Dr. Zhu has stock in Abbott lab. The institution of Dr. Zhu has received research support from NRG NIH. The institution of Dr. Zhu has received research support from Novocure, Inc. The institution of Dr. Zhu has received research support from Five Prime pharmaceutical. The institution of Dr. Zhu has received research support from Denovo, inc. The institution of Dr. Zhu has received research support from Boston Biomedical Sumitomo Dainippon Pharma Global Oncology. The institution of Dr. Zhu has received research support from CNS pharmaceutical. The institution of Dr. Zhu has received research support from ABM Therapeutics Corporation . The institution of Dr. Zhu has received research support from Chimerix Inc.
Priyanka Moondra, DO Dr. Moondra has nothing to disclose.
William Avery No disclosure on file
Ulrike Bonati Ulrike Bonati has received personal compensation for serving as an employee of Hoffman-La Roche. An immediate family member of Ulrike Bonati has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for InnoHeart. The institution of an immediate family member of Ulrike Bonati has received research support from Astra Zeneca . The institution of an immediate family member of Ulrike Bonati has received research support from Bayer. The institution of an immediate family member of Ulrike Bonati has received research support from Stiftung zur Förderung der gastroenterologischen und allgemeinen klinischen Forschung sowie der medizinischen Bildauswertung. The institution of an immediate family member of Ulrike Bonati has received research support from Swiss Heart Foundation. The institution of an immediate family member of Ulrike Bonati has received research support from Swiss National Science Foundation.
Sarah Marmol, MD Dr. Marmol has nothing to disclose.
Rajesh Kumar Singh No disclosure on file
Haruhiko Motegi, MD Dr. Motegi has nothing to disclose.
Rosario Vasta, MD Dr. Vasta has nothing to disclose.
Megan Morris No disclosure on file
Klevest Gjini No disclosure on file
Damiano Mistri, MSC Mr. Mistri has nothing to disclose.
Sandro Sorbi Sandro Sorbi has nothing to disclose.
Howard W. Sander, MD, FAAN Dr. Sander has received personal compensation for serving as an employee of Grifols. Dr. Sander has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law firm.
Charles L. Wade, MBBS Dr. Wade has nothing to disclose.
Yasamin Mahjoub, MD Dr. Mahjoub has nothing to disclose.
Maryann Mays, MD, FAAN Dr. Mays has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech Medical. Dr. Mays has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Mays has received research support from Amgen.
Milagros D. Pascual-Guevara Miss Pascual-Guevara has nothing to disclose.
Vishakhadatta Mathur Kumaraswamy, MD The institution of Dr. Mathur Kumaraswamy has received research support from Woolsey Pharmaceuticals.
Arun S. Chhabra, MD Dr. Chhabra has stock in Pfizer. Dr. Chhabra has stock in Biogen. Dr. Chhabra has stock in Johnson and Johnson. Dr. Chhabra has stock in Medtronic.
David S. Lynch, MBBS, PhD Dr. Lynch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vigil Neuroscience. Dr. Lynch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Lynch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vigil Neuroscience.
Emily White, MD Dr. White has nothing to disclose.
Daniel Ontaneda, MD, PhD, FAAN Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Robert Stern, PhD Robert Stern, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Robert Stern, PhD has received research support from Eisai. The institution of Robert Stern, PhD has received research support from Lilly. The institution of Robert Stern, PhD has received research support from ATRI/NIA. Robert Stern, PhD has received publishing royalties from a publication relating to health care. Robert Stern, PhD has a non-compensated relationship as a Member with NFLPA Mackey-White Committee that is relevant to AAN interests or activities.
Olwen Murphy, MD Dr. Murphy has nothing to disclose.
Briana Cameron, PhD Dr. Cameron has received personal compensation for serving as an employee of Genentech. Dr. Cameron has stock in Genentech.
Taha Qarni, MD Dr. Qarni has nothing to disclose.
Amulya Gottiparthy, MD Dr. Gottiparthy has nothing to disclose.
Robert E. Hogan, MD Dr. Hogan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Hogan has received research support from Biogen Inc. The institution of Dr. Hogan has received research support from Engage Therapeutics. The institution of Dr. Hogan has received research support from Otsuka Pharmaceuticals. The institution of Dr. Hogan has received research support from Cerevel Therapeutics.
Elsa Salim Karam, MD Dr. Salim Karam has nothing to disclose.
Shan E. Abbas, MD Dr. Abbas has nothing to disclose.
Maria J. Bruzzone, MD Dr. Bruzzone has nothing to disclose.
Mohsen Ahmed Mr. Ahmed has nothing to disclose.
Padmaja Sudhakar, MD Dr. Sudhakar has nothing to disclose.
Andrea Calvo, MD, PhD, FAAN Dr. Calvo has nothing to disclose.
Elise R. Hennessy, MD Dr. Hennessy has nothing to disclose.
Sai Kumar Reddy Pasya, MD, MBBS Mr. Pasya has nothing to disclose.
Tyler Kendall, MD Dr. Kendall has nothing to disclose.
Laura Hayse Ms. Hayse has nothing to disclose.
Vittorio Martinelli Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Bruno Giometto, MD Dr. Giometto has nothing to disclose.
Jamie Wong, PhD Dr. Wong has nothing to disclose.
Audrey Strongosky No disclosure on file
Rohan B. Yarlagadda, DO Mr. Yarlagadda has nothing to disclose.
Josefina Maranzano The institution of Ms. Maranzano has received research support from Natural Sciences and Engineering Research Council of Canada.
Marcos Santana Firme, MD Marcos Santana Firme has nothing to disclose.
Zbigniew K. Wszolek, MD, FAAN Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica.
Deepti Vibha, MD Dr. Vibha has nothing to disclose.
Giuseppe Fuda No disclosure on file
Jasmin Patel, MD Dr. Patel has nothing to disclose.
Faiza Ahmed, MD No disclosure on file
Monica Margoni Monica Margoni has received research support from MAGNIMS. Monica Margoni has received research support from Merck-Serono. Monica Margoni has received research support from Sanofi-Genzyme.
Vera Pertsovskaya, MD Miss Pertsovskaya has nothing to disclose.
Antonio Canosa Antonio Canosa has nothing to disclose.
Arunmozhimaran Elavarasi, MD Dr. Elavarasi has stock in Pfizer. Dr. Elavarasi has stock in PGHL. The institution of Dr. Elavarasi has received research support from All India Institute of Medical Sciences, New Delhi. The institution of Dr. Elavarasi has received research support from Indian Council for Medical Research.
Kathleen B. Mullin, MD Dr. Mullin has received personal compensation in the range of $0-$499 for serving as a Consultant for Vorso. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mullin has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Mullin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
Allahshukur Ilgarli, MD Dr. Ilgarli has nothing to disclose.
Henry Houlden No disclosure on file
Jared C. Wolfe Mr. Wolfe has nothing to disclose.
Melissa A. Wright, MD Dr. Wright has nothing to disclose.
David B. Kudrow, MD Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Kudrow has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Kudrow has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Kudrow has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Kudrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Kudrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Kudrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven.
Annelly Buré-Reyes Annelly Buré-Reyes has nothing to disclose.
Anthony P. Zampino, MD Dr. Zampino has nothing to disclose.
Charulata Venkatesan, MD, PhD Dr. Venkatesan has nothing to disclose.
Mehdi Ghasemi, MD Dr. Ghasemi has nothing to disclose.
Maurice B. Vincent, MD, PhD Prof. Vincent has received personal compensation for serving as an employee of Eli Lilly and Company. Prof. Vincent has stock in Eli Lilly and Company.
Nicanor Mori, MD Dr. Mori has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche. Dr. Mori has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Mori has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Mori has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi.
Brett Dabruzzo, PharmD Dr. Dabruzzo has received personal compensation for serving as an employee of AbbVie. Dr. Dabruzzo has stock in AbbVie.
Serena S. Hoost Ms. Hoost has nothing to disclose.
Eleni Vasileiou, MD Dr. Vasileiou has nothing to disclose.
Garima Shukla, MD, MBBS, DM, FRCPC The institution of Prof. Shukla has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Adithya Sivaraju, MD Dr. Sivaraju has nothing to disclose.
Sydney M. Shaffer, MD Dr. Shaffer has nothing to disclose.
Kelvin K. Chang Mr. Chang has nothing to disclose.
Peter P. Pacut, MD Dr. Pacut has nothing to disclose.
Miguel F. Cabanillas Lazo Mr. Cabanillas Lazo has nothing to disclose.
Bastien C. Caba Mr. Caba has received personal compensation for serving as an employee of Therapanacea. Mr. Caba has received personal compensation for serving as an employee of Biogen. Mr. Caba has received personal compensation in the range of $50,000-$99,999 for serving as a Research Engineer with Therapanacea. Mr. Caba has received personal compensation in the range of $100,000-$499,999 for serving as a Scientist II, ML/AI with Biogen.
Saul Reyes, MD Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIIB. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Reyes has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Aya N. Shnawa, MD Dr. Shnawa has nothing to disclose.
Clover Youn, MD Dr. Youn has nothing to disclose.
Jeffrey A. Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FiND. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for INMune. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage.
Orhun H. Kantarci, MD Dr. Kantarci has nothing to disclose.
Zhuoran Yao Mr. Yao has nothing to disclose.
Benjamin R. Brooks, MD, FAAN Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with American Academy of Neurology that is relevant to AAN interests or activities.
Shayan Marsia, MBBS Dr. Marsia has nothing to disclose.
Cleo Zarina A. Reyes, MD Dr. Reyes has nothing to disclose.
Andrew Russo Andrew Russo has nothing to disclose.
John A. Lincoln, MD, PhD The institution of Dr. Lincoln has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Lincoln has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Lincoln has received research support from Deaprtment of Defense. The institution of Dr. Lincoln has received research support from National Institutes of Health. The institution of Dr. Lincoln has received research support from EMD-Serono. Dr. Lincoln has received intellectual property interests from a discovery or technology relating to health care.
Matteo Albergoni, PT Dr. Albergoni has nothing to disclose.
Michael Rubin, MD, FAAN Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NeuroAlert. Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Merck Manual.
Alessandro Meani No disclosure on file
Rizamarie Empeno, MD Dr. Empeno has nothing to disclose.
Yian Gu, PhD The institution of Dr. Gu has received research support from NIH.
Corneliu C. Luca, MD Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health.
Francesco Gavazzi, MD Dr. Gavazzi has nothing to disclose.
Dylan F. Del Papa, MD Dr. Del Papa has nothing to disclose.
Steven Peters, MD Dr. Peters has nothing to disclose.
Umberto Manera, MD Dr. Manera has nothing to disclose.
Marwan N. Sabbagh, MD, FAAN Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Saniya Pervin, MD Dr. Pervin has nothing to disclose.
Ruaa Ibrahim Ms. Ibrahim has nothing to disclose.
Yohannes S. Mulatu, MD Dr. Mulatu has nothing to disclose.
Umair Azhar Mr. Azhar has nothing to disclose.
Miranda Flamholz Miss Flamholz has nothing to disclose.
Mayra Montalvo Perero, MD Dr. Montalvo Perero has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN.
Lisa Scott, MD, DO Dr. Scott has nothing to disclose.
Daniela S. Rodriguez Ms. Rodriguez has nothing to disclose.
Rose P. Griffin Ms. Griffin has nothing to disclose.
Sania Azhar Ms. Azhar has nothing to disclose.
Mellad Khoshnood, MD Dr. Khoshnood has nothing to disclose.
Rosa De Abreu Ferreira No disclosure on file
Urvi G. Desai, MD, FAAN Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Jessie A. Walker, MD Dr. Walker has nothing to disclose.
Anabel Marre, Other An immediate family member of Ms. Marre has received personal compensation for serving as an employee of EMD Serono, Inc.. An immediate family member of Ms. Marre has received personal compensation for serving as an employee of MFS Investment Management. Ms. Marre has received research support from Office of Undergraduate Research which is administered by Northwestern University's Office of the Provost.
Jeff Gao, MD No disclosure on file
Kunio Nakamura, PhD Dr. Nakamura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INmune Bio. The institution of Dr. Nakamura has received research support from Biogen. The institution of Dr. Nakamura has received research support from PCORI. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from Novartis. The institution of Dr. Nakamura has received research support from DOD. Dr. Nakamura has received intellectual property interests from a discovery or technology relating to health care.
Ahmed Saad Dr. Saad has nothing to disclose.
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has stock in NeuroRx.
Pooja Venkatesh Miss Venkatesh has nothing to disclose.
Amal Abbes Ms. Abbes has nothing to disclose.
Victor Fung, MD, MBBS, PhD Dr. Fung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fung has received publishing royalties from a publication relating to health care.
Carmela Tartaglia, MD Dr. Tartaglia has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Tartaglia has received research support from NIH. The institution of Dr. Tartaglia has received research support from University of Toronto.
Susan Hutchinson Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alder Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Allergan Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Currax Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for electroCore. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $0-$499 for serving as a Consultant for Lundbeck Pharmaceutical. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan . Susan Hutchinson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/AbbVie. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Susan Hutchinson has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Lilly Pharmaceutical . Susan Hutchinson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva . Susan Hutchinson has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . Susan Hutchinson has received publishing royalties from a publication relating to health care.
Despoina Ioannidou, PhD Dr. Ioannidou has received personal compensation for serving as an employee of Therapanacea.
Mohammad Ghatali, MD Dr. Ghatali has nothing to disclose.
Laura A. Stein, MD Dr. Stein has nothing to disclose.
Bruno Colombo Bruno Colombo has nothing to disclose.
Ryan Emmanuel, MD Mr. Emmanuel has nothing to disclose.
Rodrigo Gaudio No disclosure on file
Farren Briggs, PhD The institution of Prof. Briggs has received research support from NIH. The institution of Prof. Briggs has received research support from Michael J. Fox Foundation.
Jennifer Adrissi, MD Dr. Adrissi has nothing to disclose.
Hacer Durmus, MD Dr. Durmus has nothing to disclose.
Giovanni R. Malaty, MD Dr. Malaty has nothing to disclose.
Neel Fotedar, MD Dr. Fotedar has nothing to disclose.
Federica Boso Federica Boso has nothing to disclose.
Arman Cakar Arman Cakar has nothing to disclose.
Daniel Reich, MD, PhD Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi-Genzyme. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with PeerView. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with AcademicCME. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Integrity. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi-Genzyme that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with American Brain Foundation that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Biohaven that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sana that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Merck KGaA EMD Serono that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Bristol-Meyers Squibb that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with ChemoCentryx that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Perceptive that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities.
Henrik Zetterberg No disclosure on file
Elias S. Sotirchos, MD Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Dr. Sotirchos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Sotirchos has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Sotirchos has received research support from National Institutes of Health. The institution of Dr. Sotirchos has received research support from National Multiple Sclerosis Society. The institution of Dr. Sotirchos has received research support from Sumaira Foundation. The institution of Dr. Sotirchos has received research support from Genentech. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving as a Ad Hoc Reviewer with National Institutes of Health.
Maria A. Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Dragos Manta No disclosure on file
Ziad Alahmad Dr. Alahmad has nothing to disclose.
Danielle G. Barber, MD, PhD The institution of Dr. Barber has received research support from NIH.
Yazan S. Al-Zamer Mr. Al-Zamer has nothing to disclose.
Drew S. Kern, MD, FAAN Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Dr. Kern has received research support from Boston Scientific. The institution of Dr. Kern has received research support from AbbVie Pharmaceticals. Dr. Kern has received research support from Medtronic.
Lindsay Tetreault, MD, PhD Dr. Tetreault has nothing to disclose.
Omar Jbarah No disclosure on file
Leona Ling, PhD Dr. Ling has received personal compensation for serving as an employee of Janssen Pharmaceuticals (Johnson&Johnson). Dr. Ling has stock in Janssen Pharmaceuticals (Johnson&Johnson). Dr. Ling has received intellectual property interests from a discovery or technology relating to health care. Dr. Ling has received intellectual property interests from a discovery or technology relating to health care.
Jason S. Gill, MD, PhD Dr. Gill has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Elite Medical Experts. The institution of Dr. Gill has received research support from NIH-NINDS.
Fatemeh Seifar Ms. Seifar has nothing to disclose.
Tejas Patel No disclosure on file
John Furey Mr. Furey has nothing to disclose.
Philion Gatchoff, MD Dr. Gatchoff has nothing to disclose.
Jessica Feistel, DO Dr. Feistel has nothing to disclose.
Matthew Feldman, MD Dr. Feldman has nothing to disclose.
Francesca Palumbo No disclosure on file
Maurizio Grassano, MD Dr. Grassano has received research support from American Brain Foundation, ALS Association and American Academy of Neurology.
Chilvana V. Patel, MBBS, FAAN Dr. Patel has nothing to disclose.
Birendra Sah No disclosure on file
Ton Fang, MBBS Dr. Fang has nothing to disclose.
Andrea Mendez Colmenares, MD, PhD Dr. Mendez Colmenares has nothing to disclose.
Samah K. Aburahma, MD Dr. Aburahma has nothing to disclose.
Sydnie Jones, MD Dr. Jones has nothing to disclose.
Achal K. Srivastava, MD, FAAN Dr. Srivastava has nothing to disclose.
Linda Mosher No disclosure on file
David Clayton David Clayton has received personal compensation for serving as an employee of Genentech/Roche. David Clayton has received stock or an ownership interest from Roche. An immediate family member of David Clayton has received publishing royalties from a publication relating to health care.
Patrick Hecht, PhD Dr. Hecht has received personal compensation for serving as an employee of AbbVie. Dr. Hecht has stock in AbbVie.
Jarrett Leech, MD Dr. Leech has nothing to disclose.
Bhavya Narapureddy, MBBS Dr. Narapureddy has nothing to disclose.
Stefan Gillen, DO Dr. Gillen has nothing to disclose.
Ketevan Amirkhanashvili, MD Dr. Amirkhanashvili has nothing to disclose.
Hongxuyang Yu, MD Dr. Yu has nothing to disclose.
Karen Williams No disclosure on file
Jerry Hall Jerry Hall has received personal compensation for serving as an employee of Eli Lilly & Co.. Jerry Hall has stock in Eli Lilly & Co..
Ronak U. Trivedi Mr. Trivedi has nothing to disclose.
Jamie C. McDonald, MD Dr. McDonald has nothing to disclose.
Hussam A. Yacoub, DO Dr. Yacoub has nothing to disclose.
Gabriel I. Cassinelli Petersen Mr. Cassinelli Petersen has nothing to disclose.
Joshua Joung, Other The institution of Mr. Joung has received research support from Ionis Pharmaceuticals.
Elizabeth Fisher Elizabeth Fisher has received personal compensation for serving as an employee of Biogen. Elizabeth Fisher has stock in Biogen. Elizabeth Fisher has received intellectual property interests from a discovery or technology relating to health care.
Jorge L. Rodriguez Lee, MD Dr. Rodriguez Lee has nothing to disclose.
Stefano Callegaro No disclosure on file
Benjamin Chapin, MD Dr. Chapin has nothing to disclose.
Jason L. Weller, MD Dr. Weller has nothing to disclose.
Paolina Salamone No disclosure on file
Carolina B. Moura, MD Dr. Moura has nothing to disclose.
Susie Y. Huang, MD, PhD Dr. Huang has received personal compensation in the range of $0-$499 for serving as a Consultant for Siemens Healthineers. The institution of Dr. Huang has received research support from Siemens Healthineers. The institution of Dr. Huang has received research support from Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School.
Margaret Hoyt, PhD Dr. Hoyt has received personal compensation for serving as an employee of Eli Lilly and Co.. Dr. Hoyt has stock in Eli Lilly and Co..
Foad Taghdiri, MD, MSc Dr. Taghdiri has nothing to disclose.
Kathryn Gallison, Other The institution of Miss Gallison has received research support from Ionis Pharmaceuticals.
Eva Angela Krijnen Ms. Krijnen has nothing to disclose.
Dimitrios Kapogiannis, MD The institution of Dr. Kapogiannis has received research support from National Institute on Aging (NIA/NIH).
Aarushi Suneja, MD Dr. Suneja has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Suneja has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Gary D. Berman, MD Dr. Berman has received personal compensation for serving as an employee of Clinical Research Institute. Dr. Berman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Berman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alder. Dr. Berman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Berman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Berman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Berman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergen. Dr. Berman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven.
Derek Neilson Derek Neilson has nothing to disclose.
Srinivas Medavarapu, MD, MBBS Dr. Medavarapu has nothing to disclose.
Adeline Vanderver, MD, FAAN An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
Jenifer Cordon Miss Cordon has nothing to disclose.
Emily Spoth No disclosure on file
Cristina Moglia Cristina Moglia has nothing to disclose.
Kenji Kufukihara, MD Dr. Kufukihara has nothing to disclose.
Eric Klawiter, MD, FAAN Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech.
Aine P. Merwick, MD The institution of Dr. Merwick has received research support from Irish Institute of Clinical Neuroscience.
Benjamin J. Puccio, MD Dr. Puccio has nothing to disclose.
Danurys Sanchez No disclosure on file
Laura Gaetano Laura Gaetano has received personal compensation for serving as an employee of Roche. Laura Gaetano has received stock or an ownership interest from Roche.
Ethar Hazaimeh, MD Dr. Hazaimeh has nothing to disclose.
Muhammed Ors Mr. Ors has nothing to disclose.
Danielle Larson, MD Dr. Larson has received personal compensation in the range of $0-$499 for serving as a Consultant for Acadia Pharmaceuticals.
Jennifer J. Manly, PhD The institution of Dr. Manly has received research support from NIH. Dr. Manly has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with University of Mississippi.
David F. Tang-Wai, MD, FRCPC Dr. Tang-Wai has nothing to disclose.
Meghana Karnik-Henry Meghana Karnik-Henry has received personal compensation for serving as an employee of Lundbeck.
Badria Munir, MD Dr. Munir has nothing to disclose.
Mangayarkarasi Thandampallayam Ajjeya, MBBS Dr. Thandampallayam Ajjeya has nothing to disclose.
Estevao P. Ribeiro, MD Dr. Ribeiro has nothing to disclose.
Shiv Saidha, MD Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReWind Therapeutics. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Pharmaceuticals. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal ETC. Dr. Saidha has stock in June Brain. Dr. Saidha has stock in Lapix Therapeutics. The institution of Dr. Saidha has received research support from Biogen. The institution of Dr. Saidha has received research support from Genentech. The institution of Dr. Saidha has received research support from Novartis. The institution of Dr. Saidha has received research support from Lapix Therapeutics. The institution of Dr. Saidha has received research support from Novartis.
Faiza Ahmed Ms. Ahmed has nothing to disclose.
Cecilia Quarracino Benchetrit, MD Mrs. Quarracino Benchetrit has nothing to disclose.
Ronel Santos No disclosure on file
Phoebe Jiang, PhD Dr. Jiang has received personal compensation for serving as an employee of Biogen. Dr. Jiang has stock in Biogen.
Mario Ortega, PhD Dr. Ortega has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Abigail S. Bose, MD Dr. Bose has nothing to disclose.
Vivien Ikwuazom Vivien Ikwuazom has nothing to disclose.
Jorge E. Patino Murillas, MD Dr. Patino Murillas has nothing to disclose.
Sarah Levy, PhD Dr. Levy has nothing to disclose.